Global Pharmaceutical Contract Manufacturing Market Insights, Growth, Share, Size: By Service, By Therapeutic Area, By Form, By Clinical Phase, By Process, By Region & Segmental Forecast, 2023-2031, Comparative Analysis and Trends

Report ID :AMI-1692 | Category : Healthcare | Published Date : November, 2023 | Pages : 402 | Format :PDF

Global Pharmaceutical Contract Manufacturing Market was Valued at USD 173.1 Bn in 2022, with an Estimated CAGR of 7.5% from 2023- 2031.  

The global pharmaceutical contract manufacturing market has emerged as a foundation of the pharmaceutical industry, revolutionizing drug production and supply chains. This market involves outsourcing the manufacturing processes of pharmaceutical products to specialized third-party firms, enabling drug developers to focus on research, development, and marketing. With increasing complexities in drug formulations, stringent regulatory requirements, and the need for cost-effective production, pharmaceutical companies rely on contract manufacturing organizations (CMOs) for their expertise in manufacturing, packaging, and quality control. The market's growth is fueled by technological advancements, globalization, and the pursuit of efficiency in the delivery of life-saving medications worldwide.

Global Pharmaceutical Contract Manufacturing Market Growth Drivers 

Large pharmaceutical corporations now outsource up to 60% of their production. New restrictions force pharmaceutical businesses to rely on aligned, specialised partners like a contract manufacturing or packaging organisation (CMO/CPO) due to less production and manufacturing in-house, smaller margins, and a need to focus more intently on certain clients and segments has led to the growth in adoption of pharmaceutical contract manufacturing.

Furthermore the pandemic highlighted the importance of agile manufacturing networks. Pharmaceutical contract manufacturing played a crucial role in rapidly scaling up the production of vaccines, treatments, and essential pharmaceuticals to address the global health crisis, showcasing their responsiveness and adaptability.

Global Pharmaceutical Contract Manufacturing Market Revenue & Forecast, (US$ Million), 2015 – 2031

Global Pharmaceutical Contract Manufacturing Market

The rise of pharmaceutical contract manufacturing across clinical phases underscores its pivotal role in drug development. The companies offer tailored solutions, expertise, and flexibility, enabling pharmaceutical companies to navigate the complexities of clinical trials, ensure regulatory compliance, and efficiently bring new drugs to market. Collaborations between pharmaceutical companies and CMOs facilitate the exploration of diverse compounds and technologies, accelerating the identification and development of potential drug candidates which will foster the growth of the global the pharmaceutical contract manufacturing market.

Asia Pacific region is anticipated to be the fastest growing region in the pharmaceutical contract manufacturing market during the forecast period. In the last few years, Asia, particularly countries like India, China, and South Korea are offering cost-effective manufacturing solutions due to lower labor costs, infrastructure expenses, and operational expenditures compared to Western countries. This cost efficiency has attracted pharmaceutical companies seeking to optimize production expenses. Additionally the rapid expansion of the pharmaceutical industry in Asia, fueled by increased demand for healthcare services, a rising middle class, and a growing aging population, has created a robust market for pharmaceutical contract manufacturing market.

Competitive Landscape

The competitive landscape in pharmaceutical contract manufacturing market is shaped by factors such as technological advancements, geographic expansion, strategic collaborations, and a focus on offering end-to-end solutions to pharmaceutical companies. The report provides an in-depth analysis of the recent collaboration, strategic partnerships, and mergers and acquisitions of the market participants to expand their presence in this competitive market.

Some of the players operating in the global pharmaceutical contract manufacturing market are

  • AbbVie Inc.
  • Akums Drugs and Pharmaceuticals Ltd.
  • Avara Pharmaceutical Services, Inc
  • Cambrex Corporation
  • Cirondrugs
  • Curia Global, Inc.
  • Datex Corporation
  • Jubilant Pharmova Limited
  • Labcorp Drug Development 
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Sovereign Pharmaceuticals.
  • Thermo Fisher Scientific Inc
  • WuXiAppTec
  • Other Industry Participants

Global Pharmaceutical Contract Manufacturing Market

By Service

  • Drug discovery
  • Drug manufacturing and commercial production
  • Documentation of compliance with FDA regulatory requirements
  • Pre-formulation
  • Providing late-stage clinical trial materials
  • Providing formal stability, scale-up, registration batches
  • API manufacturing
  • Others

By Therapeutic Area

  • Autoimmune Diseases
  • Oncology
  • Metabolic Diseases
  • Ophthalmology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Respiratory Disorders
  • Others

By Form 

  • Solid
    • Tablets and Capsules
    • Compressed tablets
    • Micro and mini tablets
    • Aqueous film coated tablets
    • Others
  • Liquid
    • Oral Solutions
    • Topical Solutions
  • Semi-solid
    • Creams
    • Gels
    • Ointments
    • Others

 By Clinical Phase 

  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Commercial

By Process

  • Commercial Production
    • Small scale
    • Large Scale
  • Clinical Production
  • Aseptic Filling
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)  


Table of Contents

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2021

1.2.2. Base Year: 2022

1.2.3. Forecast Years: 2023 – 2031

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Pharmaceutical Contract Manufacturing Market

6.    Market Synopsis:  Pharmaceutical Contract Manufacturing Market

7.    Pharmaceutical Contract Manufacturing Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Pharmaceutical Contract Manufacturing Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Pharmaceutical Contract Manufacturing Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Pharmaceutical Contract Manufacturing Market

8.    Global Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

8.1. Overview

8.1.1. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

8.2. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

8.2.1. Drug discovery

8.2.1.1.    Definition

8.2.1.2.    Market Estimation and Penetration, 2015 - 2022

8.2.1.3.    Market Forecast, 2023 - 2031

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.1.5.    Regional Bifurcation

8.2.1.5.1.    North America

8.2.1.5.1.1. Market Estimation, 2015 - 2022

8.2.1.5.1.2. Market Forecast, 2023 - 2031

8.2.1.5.2.    Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2022

8.2.1.5.2.2. Market Forecast, 2023 - 2031

8.2.1.5.3.    Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2022

8.2.1.5.3.2. Market Forecast, 2023 - 2031

8.2.1.5.4.    Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2022

8.2.1.5.4.2. Market Forecast, 2023 - 2031

8.2.1.5.5.    Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2022

8.2.1.5.5.2. Market Forecast, 2023 - 2031

8.2.2. Drug manufacturing and commercial production

8.2.2.1.    Definition

8.2.2.2.    Market Estimation and Penetration, 2015 - 2022

8.2.2.3.    Market Forecast, 2023 - 2031

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.2.5.    Regional Bifurcation

8.2.2.5.1.    North America

8.2.2.5.1.1. Market Estimation, 2015 - 2022

8.2.2.5.1.2. Market Forecast, 2023 - 2031

8.2.2.5.2.    Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2022

8.2.2.5.2.2. Market Forecast, 2023 - 2031

8.2.2.5.3.    Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2022

8.2.2.5.3.2. Market Forecast, 2023 - 2031

8.2.2.5.4.    Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2022

8.2.2.5.4.2. Market Forecast, 2023 - 2031

8.2.2.5.5.    Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2022

8.2.2.5.5.2. Market Forecast, 2023 - 2031

8.2.3. Documentation of compliance with FDA regulatory requirements

8.2.3.1.    Definition

8.2.3.2.    Market Estimation and Penetration, 2015 - 2022

8.2.3.3.    Market Forecast, 2023 - 2031

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.3.5.    Regional Bifurcation

8.2.3.5.1.    North America

8.2.3.5.1.1. Market Estimation, 2015 - 2022

8.2.3.5.1.2. Market Forecast, 2023 - 2031

8.2.3.5.2.    Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2022

8.2.3.5.2.2. Market Forecast, 2023 - 2031

8.2.3.5.3.    Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2022

8.2.3.5.3.2. Market Forecast, 2023 - 2031

8.2.3.5.4.    Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2022

8.2.3.5.4.2. Market Forecast, 2023 - 2031

8.2.3.5.5.    Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2022

8.2.3.5.5.2. Market Forecast, 2023 - 2031

8.2.4. Pre-formulation

8.2.4.1.    Definition

8.2.4.2.    Market Estimation and Penetration, 2015 - 2022

8.2.4.3.    Market Forecast, 2023 - 2031

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.2.4.5.    Regional Bifurcation

8.2.4.5.1.    North America

8.2.4.5.1.1. Market Estimation, 2015 - 2022

8.2.4.5.1.2. Market Forecast, 2023 - 2031

8.2.4.5.2.    Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2022

8.2.4.5.2.2. Market Forecast, 2023 - 2031

8.2.4.5.3.    Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2022

8.2.4.5.3.2. Market Forecast, 2023 - 2031

8.2.4.5.4.    Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2022

8.2.4.5.4.2. Market Forecast, 2023 - 2031

8.2.4.5.5.    Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2022

8.2.4.5.5.2. Market Forecast, 2023 - 2031

8.2.5. Providing late-stage clinical trial materials

8.2.5.1.    Definition

8.2.5.2.    Market Estimation and Penetration, 2015 - 2022

8.2.5.3.    Market Forecast, 2023 - 2031

8.2.5.4.    Compound Annual Growth Rate (CAGR)

8.2.5.5.    Regional Bifurcation

8.2.5.5.1.    North America

8.2.5.5.1.1. Market Estimation, 2015 - 2022

8.2.5.5.1.2. Market Forecast, 2023 - 2031

8.2.5.5.2.    Europe

8.2.5.5.2.1. Market Estimation, 2015 - 2022

8.2.5.5.2.2. Market Forecast, 2023 - 2031

8.2.5.5.3.    Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 - 2022

8.2.5.5.3.2. Market Forecast, 2023 - 2031

8.2.5.5.4.    Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 - 2022

8.2.5.5.4.2. Market Forecast, 2023 - 2031

8.2.5.5.5.    Latin America

8.2.5.5.5.1. Market Estimation, 2015 - 2022

8.2.5.5.5.2. Market Forecast, 2023 - 2031

8.2.6. Providing formal stability, scale-up, registration batches

8.2.6.1.    Definition

8.2.6.2.    Market Estimation and Penetration, 2015 - 2022

8.2.6.3.    Market Forecast, 2023 - 2031

8.2.6.4.    Compound Annual Growth Rate (CAGR)

8.2.6.5.    Regional Bifurcation

8.2.6.5.1.    North America

8.2.6.5.1.1. Market Estimation, 2015 - 2022

8.2.6.5.1.2. Market Forecast, 2023 - 2031

8.2.6.5.2.    Europe

8.2.6.5.2.1. Market Estimation, 2015 - 2022

8.2.6.5.2.2. Market Forecast, 2023 - 2031

8.2.6.5.3.    Asia Pacific

8.2.6.5.3.1. Market Estimation, 2015 - 2022

8.2.6.5.3.2. Market Forecast, 2023 - 2031

8.2.6.5.4.    Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2015 - 2022

8.2.6.5.4.2. Market Forecast, 2023 - 2031

8.2.6.5.5.    Latin America

8.2.6.5.5.1. Market Estimation, 2015 - 2022

8.2.6.5.5.2. Market Forecast, 2023 - 2031

8.2.7. API manufacturing

8.2.7.1.    Definition

8.2.7.2.    Market Estimation and Penetration, 2015 - 2022

8.2.7.3.    Market Forecast, 2023 - 2031

8.2.7.4.    Compound Annual Growth Rate (CAGR)

8.2.7.5.    Regional Bifurcation

8.2.7.5.1.    North America

8.2.7.5.1.1. Market Estimation, 2015 - 2022

8.2.7.5.1.2. Market Forecast, 2023 - 2031

8.2.7.5.2.    Europe

8.2.7.5.2.1. Market Estimation, 2015 - 2022

8.2.7.5.2.2. Market Forecast, 2023 - 2031

8.2.7.5.3.    Asia Pacific

8.2.7.5.3.1. Market Estimation, 2015 - 2022

8.2.7.5.3.2. Market Forecast, 2023 - 2031

8.2.7.5.4.    Middle East and Africa

8.2.7.5.4.1. Market Estimation, 2015 - 2022

8.2.7.5.4.2. Market Forecast, 2023 - 2031

8.2.7.5.5.    Latin America

8.2.7.5.5.1. Market Estimation, 2015 - 2022

8.2.7.5.5.2. Market Forecast, 2023 - 2031

8.2.8. Others

8.2.8.1.    Definition

8.2.8.2.    Market Estimation and Penetration, 2015 - 2022

8.2.8.3.    Market Forecast, 2023 - 2031

8.2.8.4.    Compound Annual Growth Rate (CAGR)

8.2.8.5.    Regional Bifurcation

8.2.8.5.1.    North America

8.2.8.5.1.1. Market Estimation, 2015 - 2022

8.2.8.5.1.2. Market Forecast, 2023 - 2031

8.2.8.5.2.    Europe

8.2.8.5.2.1. Market Estimation, 2015 - 2022

8.2.8.5.2.2. Market Forecast, 2023 - 2031

8.2.8.5.3.    Asia Pacific

8.2.8.5.3.1. Market Estimation, 2015 - 2022

8.2.8.5.3.2. Market Forecast, 2023 - 2031

8.2.8.5.4.    Middle East and Africa

8.2.8.5.4.1. Market Estimation, 2015 - 2022

8.2.8.5.4.2. Market Forecast, 2023 - 2031

8.2.8.5.5.    Latin America

8.2.8.5.5.1. Market Estimation, 2015 - 2022

8.2.8.5.5.2. Market Forecast, 2023 - 2031

8.3. Key Segment for Channeling Investments

8.3.1. By Service

9.    Global Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

9.1. Overview

9.2. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

9.2.1. Autoimmune Diseases

9.2.1.1.    Definition

9.2.1.2.    Market Estimation and Penetration, 2015 - 2022

9.2.1.3.    Market Forecast, 2023 - 2031

9.2.1.4.    Compound Annual Growth Rate (CAGR)

9.2.1.5.    Regional Bifurcation

9.2.1.5.1.    North America

9.2.1.5.1.1. Market Estimation, 2015 - 2022

9.2.1.5.1.2. Market Forecast, 2023 - 2031

9.2.1.5.2.    Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2022

9.2.1.5.2.2. Market Forecast, 2023 - 2031

9.2.1.5.3.    Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2022

9.2.1.5.3.2. Market Forecast, 2023 - 2031

9.2.1.5.4.    Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2022

9.2.1.5.4.2. Market Forecast, 2023 - 2031

9.2.1.5.5.    Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2022

9.2.1.5.5.2. Market Forecast, 2023 - 2031

9.2.2. Oncology

9.2.2.1.    Definition

9.2.2.2.    Market Estimation and Penetration, 2015 - 2022

9.2.2.3.    Market Forecast, 2023 - 2031

9.2.2.4.    Compound Annual Growth Rate (CAGR)

9.2.2.5.    Regional Bifurcation

9.2.2.5.1.    North America

9.2.2.5.1.1. Market Estimation, 2015 - 2022

9.2.2.5.1.2. Market Forecast, 2023 - 2031

9.2.2.5.2.    Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2022

9.2.2.5.2.2. Market Forecast, 2023 - 2031

9.2.2.5.3.    Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2022

9.2.2.5.3.2. Market Forecast, 2023 - 2031

9.2.2.5.4.    Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2022

9.2.2.5.4.2. Market Forecast, 2023 - 2031

9.2.2.5.5.    Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2022

9.2.2.5.5.2. Market Forecast, 2023 - 2031

9.2.3. Metabolic Diseases

9.2.3.1.    Definition

9.2.3.2.    Market Estimation and Penetration, 2015 - 2022

9.2.3.3.    Market Forecast, 2023 - 2031

9.2.3.4.    Compound Annual Growth Rate (CAGR)

9.2.3.5.    Regional Bifurcation

9.2.3.5.1.    North America

9.2.3.5.1.1. Market Estimation, 2015 - 2022

9.2.3.5.1.2. Market Forecast, 2023 - 2031

9.2.3.5.2.    Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2022

9.2.3.5.2.2. Market Forecast, 2023 - 2031

9.2.3.5.3.    Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2022

9.2.3.5.3.2. Market Forecast, 2023 - 2031

9.2.3.5.4.    Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2022

9.2.3.5.4.2. Market Forecast, 2023 - 2031

9.2.3.5.5.    Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2022

9.2.3.5.5.2. Market Forecast, 2023 - 2031

9.2.4. Ophthalmology

9.2.4.1.    Definition

9.2.4.2.    Market Estimation and Penetration, 2015 - 2022

9.2.4.3.    Market Forecast, 2023 - 2031

9.2.4.4.    Compound Annual Growth Rate (CAGR)

9.2.4.5.    Regional Bifurcation

9.2.4.5.1.    North America

9.2.4.5.1.1. Market Estimation, 2015 - 2022

9.2.4.5.1.2. Market Forecast, 2023 - 2031

9.2.4.5.2.    Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2022

9.2.4.5.2.2. Market Forecast, 2023 - 2031

9.2.4.5.3.    Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2022

9.2.4.5.3.2. Market Forecast, 2023 - 2031

9.2.4.5.4.    Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2022

9.2.4.5.4.2. Market Forecast, 2023 - 2031

9.2.4.5.5.    Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2022

9.2.4.5.5.2. Market Forecast, 2023 - 2031

9.2.5. Cardiovascular Diseases

9.2.5.1.    Definition

9.2.5.2.    Market Estimation and Penetration, 2015 - 2022

9.2.5.3.    Market Forecast, 2023 - 2031

9.2.5.4.    Compound Annual Growth Rate (CAGR)

9.2.5.5.    Regional Bifurcation

9.2.5.5.1.    North America

9.2.5.5.1.1. Market Estimation, 2015 - 2022

9.2.5.5.1.2. Market Forecast, 2023 - 2031

9.2.5.5.2.    Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2022

9.2.5.5.2.2. Market Forecast, 2023 - 2031

9.2.5.5.3.    Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2022

9.2.5.5.3.2. Market Forecast, 2023 - 2031

9.2.5.5.4.    Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2022

9.2.5.5.4.2. Market Forecast, 2023 - 2031

9.2.5.5.5.    Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2022

9.2.5.5.5.2. Market Forecast, 2023 - 2031

9.2.6. Infectious Diseases

9.2.6.1.    Definition

9.2.6.2.    Market Estimation and Penetration, 2015 - 2022

9.2.6.3.    Market Forecast, 2023 - 2031

9.2.6.4.    Compound Annual Growth Rate (CAGR)

9.2.6.5.    Regional Bifurcation

9.2.6.5.1.    North America

9.2.6.5.1.1. Market Estimation, 2015 - 2022

9.2.6.5.1.2. Market Forecast, 2023 - 2031

9.2.6.5.2.    Europe

9.2.6.5.2.1. Market Estimation, 2015 - 2022

9.2.6.5.2.2. Market Forecast, 2023 - 2031

9.2.6.5.3.    Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 - 2022

9.2.6.5.3.2. Market Forecast, 2023 - 2031

9.2.6.5.4.    Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 - 2022

9.2.6.5.4.2. Market Forecast, 2023 - 2031

9.2.6.5.5.    Latin America

9.2.6.5.5.1. Market Estimation, 2015 - 2022

9.2.6.5.5.2. Market Forecast, 2023 - 2031

9.2.7. Neurology

9.2.7.1.    Definition

9.2.7.2.    Market Estimation and Penetration, 2015 - 2022

9.2.7.3.    Market Forecast, 2023 - 2031

9.2.7.4.    Compound Annual Growth Rate (CAGR)

9.2.7.5.    Regional Bifurcation

9.2.7.5.1.    North America

9.2.7.5.1.1. Market Estimation, 2015 - 2022

9.2.7.5.1.2. Market Forecast, 2023 - 2031

9.2.7.5.2.    Europe

9.2.7.5.2.1. Market Estimation, 2015 - 2022

9.2.7.5.2.2. Market Forecast, 2023 - 2031

9.2.7.5.3.    Asia Pacific

9.2.7.5.3.1. Market Estimation, 2015 - 2022

9.2.7.5.3.2. Market Forecast, 2023 - 2031

9.2.7.5.4.    Middle East and Africa

9.2.7.5.4.1. Market Estimation, 2015 - 2022

9.2.7.5.4.2. Market Forecast, 2023 - 2031

9.2.7.5.5.    Latin America

9.2.7.5.5.1. Market Estimation, 2015 - 2022

9.2.7.5.5.2. Market Forecast, 2023 - 2031

9.2.8. Respiratory Disorders

9.2.8.1.    Definition

9.2.8.2.    Market Estimation and Penetration, 2015 - 2022

9.2.8.3.    Market Forecast, 2023 - 2031

9.2.8.4.    Compound Annual Growth Rate (CAGR)

9.2.8.5.    Regional Bifurcation

9.2.8.5.1.    North America

9.2.8.5.1.1. Market Estimation, 2015 - 2022

9.2.8.5.1.2. Market Forecast, 2023 - 2031

9.2.8.5.2.    Europe

9.2.8.5.2.1. Market Estimation, 2015 - 2022

9.2.8.5.2.2. Market Forecast, 2023 - 2031

9.2.8.5.3.    Asia Pacific

9.2.8.5.3.1. Market Estimation, 2015 - 2022

9.2.8.5.3.2. Market Forecast, 2023 - 2031

9.2.8.5.4.    Middle East and Africa

9.2.8.5.4.1. Market Estimation, 2015 - 2022

9.2.8.5.4.2. Market Forecast, 2023 - 2031

9.2.8.5.5.    Latin America

9.2.8.5.5.1. Market Estimation, 2015 - 2022

9.2.8.5.5.2. Market Forecast, 2023 - 2031

9.2.9. Others

9.2.9.1.    Definition

9.2.9.2.    Market Estimation and Penetration, 2015 - 2022

9.2.9.3.    Market Forecast, 2023 - 2031

9.2.9.4.    Compound Annual Growth Rate (CAGR)

9.2.9.5.    Regional Bifurcation

9.2.9.5.1.    North America

9.2.9.5.1.1. Market Estimation, 2015 - 2022

9.2.9.5.1.2. Market Forecast, 2023 - 2031

9.2.9.5.2.    Europe

9.2.9.5.2.1. Market Estimation, 2015 - 2022

9.2.9.5.2.2. Market Forecast, 2023 - 2031

9.2.9.5.3.    Asia Pacific

9.2.9.5.3.1. Market Estimation, 2015 - 2022

9.2.9.5.3.2. Market Forecast, 2023 - 2031

9.2.9.5.4.    Middle East and Africa

9.2.9.5.4.1. Market Estimation, 2015 - 2022

9.2.9.5.4.2. Market Forecast, 2023 - 2031

9.2.9.5.5.    Latin America

9.2.9.5.5.1. Market Estimation, 2015 - 2022

9.2.9.5.5.2. Market Forecast, 2023 - 2031

9.3. Key Segment for Channeling Investments

9.3.1. By Therapeutic Area

10. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

10.1. Overview

10.2. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

10.2.1. Solid (Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Tablets and Capsules , Compressed tablets, Micro and mini tablets, Aqueous film coated tablets, Others)

10.2.1.1.  Tablets and Capsules

10.2.1.2.  Compressed tablets

10.2.1.3.  Micro and mini tablets

10.2.1.4.  Aqueous film coated tablets

10.2.1.5.  Others

10.2.2. Liquid (Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Oral Solutions , Topical Solutions)

10.2.2.1.  Oral Solutions

10.2.2.2.  Topical Solutions

10.2.3. Semi-solid (Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023 -2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Creams, Gels, Ointments, Others )

10.2.3.1.  Creams

10.2.3.2.  Gels

10.2.3.3.  Ointments

10.2.3.4.  Others

10.3. Key Segment for Channeling Investments

10.3.1. By Form

11. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

11.1. Overview

11.2. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

11.2.1. Preclinical

11.2.1.1.  Definition

11.2.1.2.  Market Estimation and Penetration, 2015 - 2022

11.2.1.3.  Market Forecast, 2023 - 2031

11.2.1.4.  Compound Annual Growth Rate (CAGR)

11.2.1.5.  Regional Bifurcation

11.2.1.5.1.  North America

11.2.1.5.1.1. Market Estimation, 2015 - 2022

11.2.1.5.1.2. Market Forecast, 2023 - 2031

11.2.1.5.2.  Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2022

11.2.1.5.2.2. Market Forecast, 2023 - 2031

11.2.1.5.3.  Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2022

11.2.1.5.3.2. Market Forecast, 2023 - 2031

11.2.1.5.4.  Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2022

11.2.1.5.4.2. Market Forecast, 2023 - 2031

11.2.1.5.5.  Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2022

11.2.1.5.5.2. Market Forecast, 2023 - 2031

11.2.2. Phase 1

11.2.2.1.  Definition

11.2.2.2.  Market Estimation and Penetration, 2015 - 2022

11.2.2.3.  Market Forecast, 2023 - 2031

11.2.2.4.  Compound Annual Growth Rate (CAGR)

11.2.2.5.  Regional Bifurcation

11.2.2.5.1.  North America

11.2.2.5.1.1. Market Estimation, 2015 - 2022

11.2.2.5.1.2. Market Forecast, 2023 - 2031

11.2.2.5.2.  Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2022

11.2.2.5.2.2. Market Forecast, 2023 - 2031

11.2.2.5.3.  Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2022

11.2.2.5.3.2. Market Forecast, 2023 - 2031

11.2.2.5.4.  Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2022

11.2.2.5.4.2. Market Forecast, 2023 - 2031

11.2.2.5.5.  Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2022

11.2.2.5.5.2. Market Forecast, 2023 - 2031

11.2.3. Phase 2

11.2.3.1.  Definition

11.2.3.2.  Market Estimation and Penetration, 2015 - 2022

11.2.3.3.  Market Forecast, 2023 - 2031

11.2.3.4.  Compound Annual Growth Rate (CAGR)

11.2.3.5.  Regional Bifurcation

11.2.3.5.1.  North America

11.2.3.5.1.1. Market Estimation, 2015 - 2022

11.2.3.5.1.2. Market Forecast, 2023 - 2031

11.2.3.5.2.  Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2022

11.2.3.5.2.2. Market Forecast, 2023 - 2031

11.2.3.5.3.  Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2022

11.2.3.5.3.2. Market Forecast, 2023 - 2031

11.2.3.5.4.  Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2022

11.2.3.5.4.2. Market Forecast, 2023 - 2031

11.2.3.5.5.  Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2022

11.2.3.5.5.2. Market Forecast, 2023 - 2031

11.2.4. Phase 3

11.2.4.1.  Definition

11.2.4.2.  Market Estimation and Penetration, 2015 - 2022

11.2.4.3.  Market Forecast, 2023 - 2031

11.2.4.4.  Compound Annual Growth Rate (CAGR)

11.2.4.5.  Regional Bifurcation

11.2.4.5.1.  North America

11.2.4.5.1.1. Market Estimation, 2015 - 2022

11.2.4.5.1.2. Market Forecast, 2023 - 2031

11.2.4.5.2.  Europe

11.2.4.5.2.1. Market Estimation, 2015 - 2022

11.2.4.5.2.2. Market Forecast, 2023 - 2031

11.2.4.5.3.  Asia Pacific

11.2.4.5.3.1. Market Estimation, 2015 - 2022

11.2.4.5.3.2. Market Forecast, 2023 - 2031

11.2.4.5.4.  Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2015 - 2022

11.2.4.5.4.2. Market Forecast, 2023 - 2031

11.2.4.5.5.  Latin America

11.2.4.5.5.1. Market Estimation, 2015 - 2022

11.2.4.5.5.2. Market Forecast, 2023 - 2031

11.2.5. Phase 4

11.2.5.1.  Definition

11.2.5.2.  Market Estimation and Penetration, 2015 - 2022

11.2.5.3.  Market Forecast, 2023 - 2031

11.2.5.4.  Compound Annual Growth Rate (CAGR)

11.2.5.5.  Regional Bifurcation

11.2.5.5.1.  North America

11.2.5.5.1.1. Market Estimation, 2015 - 2022

11.2.5.5.1.2. Market Forecast, 2023 - 2031

11.2.5.5.2.  Europe

11.2.5.5.2.1. Market Estimation, 2015 - 2022

11.2.5.5.2.2. Market Forecast, 2023 - 2031

11.2.5.5.3.  Asia Pacific

11.2.5.5.3.1. Market Estimation, 2015 - 2022

11.2.5.5.3.2. Market Forecast, 2023 - 2031

11.2.5.5.4.  Middle East and Africa

11.2.5.5.4.1. Market Estimation, 2015 - 2022

11.2.5.5.4.2. Market Forecast, 2023 - 2031

11.2.5.5.5.  Latin America

11.2.5.5.5.1. Market Estimation, 2015 - 2022

11.2.5.5.5.2. Market Forecast, 2023 - 2031

11.2.6. Commercial

11.2.6.1.  Definition

11.2.6.2.  Market Estimation and Penetration, 2015 - 2022

11.2.6.3.  Market Forecast, 2023 - 2031

11.2.6.4.  Compound Annual Growth Rate (CAGR)

11.2.6.5.  Regional Bifurcation

11.2.6.5.1.  North America

11.2.6.5.1.1. Market Estimation, 2015 - 2022

11.2.6.5.1.2. Market Forecast, 2023 - 2031

11.2.6.5.2.  Europe

11.2.6.5.2.1. Market Estimation, 2015 - 2022

11.2.6.5.2.2. Market Forecast, 2023 - 2031

11.2.6.5.3.  Asia Pacific

11.2.6.5.3.1. Market Estimation, 2015 - 2022

11.2.6.5.3.2. Market Forecast, 2023 - 2031

11.2.6.5.4.  Middle East and Africa

11.2.6.5.4.1. Market Estimation, 2015 - 2022

11.2.6.5.4.2. Market Forecast, 2023 - 2031

11.2.6.5.5.  Latin America

11.2.6.5.5.1. Market Estimation, 2015 - 2022

11.2.6.5.5.2. Market Forecast, 2023 - 2031

11.3. Key Segment for Channeling Investments

11.3.1. By Clinical Phase

12. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

12.1. Overview

12.2. Global Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

12.2.1. Commercial Production  (Definition, Market Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Small scale , Large Scale )

12.2.1.1.  Small scale

12.2.1.2.  Large Scale

12.2.2. Clinical Production

12.2.2.1.  Definition

12.2.2.2.  Market Estimation and Penetration, 2015 - 2022

12.2.2.3.  Market Forecast, 2023 - 2031

12.2.2.4.  Compound Annual Growth Rate (CAGR)

12.2.2.5.  Regional Bifurcation

12.2.2.5.1.  North America

12.2.2.5.1.1. Market Estimation, 2015 - 2022

12.2.2.5.1.2. Market Forecast, 2023 - 2031

12.2.2.5.2.  Europe

12.2.2.5.2.1. Market Estimation, 2015 - 2022

12.2.2.5.2.2. Market Forecast, 2023 - 2031

12.2.2.5.3.  Asia Pacific

12.2.2.5.3.1. Market Estimation, 2015 - 2022

12.2.2.5.3.2. Market Forecast, 2023 - 2031

12.2.2.5.4.  Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2015 - 2022

12.2.2.5.4.2. Market Forecast, 2023 - 2031

12.2.2.5.5.  Latin America

12.2.2.5.5.1. Market Estimation, 2015 - 2022

12.2.2.5.5.2. Market Forecast, 2023 - 2031

12.2.3. Aseptic Filling

12.2.3.1.  Definition

12.2.3.2.  Market Estimation and Penetration, 2015 - 2022

12.2.3.3.  Market Forecast, 2023 - 2031

12.2.3.4.  Compound Annual Growth Rate (CAGR)

12.2.3.5.  Regional Bifurcation

12.2.3.5.1.  North America

12.2.3.5.1.1. Market Estimation, 2015 - 2022

12.2.3.5.1.2. Market Forecast, 2023 - 2031

12.2.3.5.2.  Europe

12.2.3.5.2.1. Market Estimation, 2015 - 2022

12.2.3.5.2.2. Market Forecast, 2023 - 2031

12.2.3.5.3.  Asia Pacific

12.2.3.5.3.1. Market Estimation, 2015 - 2022

12.2.3.5.3.2. Market Forecast, 2023 - 2031

12.2.3.5.4.  Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2015 - 2022

12.2.3.5.4.2. Market Forecast, 2023 - 2031

12.2.3.5.5.  Latin America

12.2.3.5.5.1. Market Estimation, 2015 - 2022

12.2.3.5.5.2. Market Forecast, 2023 - 2031

12.2.4. Others

12.2.4.1.  Definition

12.2.4.2.  Market Estimation and Penetration, 2015 - 2022

12.2.4.3.  Market Forecast, 2023 - 2031

12.2.4.4.  Compound Annual Growth Rate (CAGR)

12.2.4.5.  Regional Bifurcation

12.2.4.5.1.  North America

12.2.4.5.1.1. Market Estimation, 2015 - 2022

12.2.4.5.1.2. Market Forecast, 2023 - 2031

12.2.4.5.2.  Europe

12.2.4.5.2.1. Market Estimation, 2015 - 2022

12.2.4.5.2.2. Market Forecast, 2023 - 2031

12.2.4.5.3.  Asia Pacific

12.2.4.5.3.1. Market Estimation, 2015 - 2022

12.2.4.5.3.2. Market Forecast, 2023 - 2031

12.2.4.5.4.  Middle East and Africa

12.2.4.5.4.1. Market Estimation, 2015 - 2022

12.2.4.5.4.2. Market Forecast, 2023 - 2031

12.2.4.5.5.  Latin America

12.2.4.5.5.1. Market Estimation, 2015 - 2022

12.2.4.5.5.2. Market Forecast, 2023 - 2031

12.3. Key Segment for Channeling Investments

12.3.1. By Process

13. North America Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

13.1. Overview

13.1.1. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

13.2. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

13.2.1. Drug discovery

13.2.2. Drug manufacturing and commercial production

13.2.3. Documentation of compliance with FDA regulatory requirements

13.2.4. Pre-formulation

13.2.5. Providing late-stage clinical trial materials

13.2.6. Providing formal stability, scale-up, registration batches

13.2.7. API manufacturing

13.2.8. Others

13.3. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

13.3.1. Autoimmune Diseases

13.3.2. Oncology

13.3.3. Metabolic Diseases

13.3.4. Ophthalmology

13.3.5. Cardiovascular Diseases

13.3.6. Infectious Diseases

13.3.7. Neurology

13.3.8. Respiratory Disorders

13.3.9. Others

13.4. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

13.4.1. Solid

13.4.1.1.  Tablets and Capsules

13.4.1.2.  Compressed tablets

13.4.1.3.  Micro and mini tablets

13.4.1.4.  Aqueous film coated tablets

13.4.1.5.  Others

13.4.2. Liquid

13.4.2.1.  Oral Solutions

13.4.2.2.  Topical Solutions

13.4.3. Semi-solid

13.4.3.1.  Creams

13.4.3.2.  Gels

13.4.3.3.  Ointments

13.4.3.4.  Others

13.5. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

13.5.1. Preclinical

13.5.2. Phase 1

13.5.3. Phase 2

13.5.4. Phase 3

13.5.5. Phase 4

13.5.6. Commercial

13.6. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

13.6.1. Commercial Production

13.6.1.1.  Small scale

13.6.1.2.  Large Scale

13.6.2. Clinical Production

13.6.3. Aseptic Filling

13.6.4. Others

13.7. North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1.  U.S Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

13.7.1.1.1.  Drug discovery

13.7.1.1.2.  Drug manufacturing and commercial production

13.7.1.1.3.  Documentation of compliance with FDA regulatory requirements

13.7.1.1.4.  Pre-formulation

13.7.1.1.5.  Providing late-stage clinical trial materials

13.7.1.1.6.  Providing formal stability, scale-up, registration batches

13.7.1.1.7.  API manufacturing

13.7.1.1.8.  Others

13.7.1.2.  U.S Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

13.7.1.2.1.  Autoimmune Diseases

13.7.1.2.2.  Oncology

13.7.1.2.3.  Metabolic Diseases

13.7.1.2.4.  Ophthalmology

13.7.1.2.5.  Cardiovascular Diseases

13.7.1.2.6.  Infectious Diseases

13.7.1.2.7.  Neurology

13.7.1.2.8.  Respiratory Disorders

13.7.1.2.9.  Others

13.7.1.3.  U.S Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

13.7.1.3.1.  Solid

13.7.1.3.1.1. Tablets and Capsules

13.7.1.3.1.2. Compressed tablets

13.7.1.3.1.3. Micro and mini tablets

13.7.1.3.1.4. Aqueous film coated tablets

13.7.1.3.1.5. Others

13.7.1.3.2.  Liquid

13.7.1.3.2.1. Oral Solutions

13.7.1.3.2.2. Topical Solutions

13.7.1.3.3.  Semi-solid

13.7.1.3.3.1. Creams

13.7.1.3.3.2. Gels

13.7.1.3.3.3. Ointments

13.7.1.3.3.4. Others

13.7.1.4.  U.S Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

13.7.1.4.1.  Preclinical

13.7.1.4.2.  Phase 1

13.7.1.4.3.  Phase 2

13.7.1.4.4.  Phase 3

13.7.1.4.5.  Phase 4

13.7.1.4.6.  Commercial

13.7.1.5.  U.S Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

13.7.1.5.1.  Commercial Production

13.7.1.5.1.1. Small scale

13.7.1.5.1.2. Large Scale

13.7.1.5.2.  Clinical Production

13.7.1.5.3.  Aseptic Filling

13.7.1.5.4.  Others

13.7.2. Canada

13.7.2.1.  Canada Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

13.7.2.1.1.  Drug discovery

13.7.2.1.2.  Drug manufacturing and commercial production

13.7.2.1.3.  Documentation of compliance with FDA regulatory requirements

13.7.2.1.4.  Pre-formulation

13.7.2.1.5.  Providing late-stage clinical trial materials

13.7.2.1.6.  Providing formal stability, scale-up, registration batches

13.7.2.1.7.  API manufacturing

13.7.2.1.8.  Others

13.7.2.2.  Canada Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

13.7.2.2.1.  Autoimmune Diseases

13.7.2.2.2.  Oncology

13.7.2.2.3.  Metabolic Diseases

13.7.2.2.4.  Ophthalmology

13.7.2.2.5.  Cardiovascular Diseases

13.7.2.2.6.  Infectious Diseases

13.7.2.2.7.  Neurology

13.7.2.2.8.  Respiratory Disorders

13.7.2.2.9.  Others

13.7.2.3.  Canada Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

13.7.2.3.1.  Solid

13.7.2.3.1.1. Tablets and Capsules

13.7.2.3.1.2. Compressed tablets

13.7.2.3.1.3. Micro and mini tablets

13.7.2.3.1.4. Aqueous film coated tablets

13.7.2.3.1.5. Others

13.7.2.3.2.  Liquid

13.7.2.3.2.1. Oral Solutions

13.7.2.3.2.2. Topical Solutions

13.7.2.3.3.  Semi-solid

13.7.2.3.3.1. Creams

13.7.2.3.3.2. Gels

13.7.2.3.3.3. Ointments

13.7.2.3.3.4. Others

13.7.2.4.  Canada Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

13.7.2.4.1.  Preclinical

13.7.2.4.2.  Phase 1

13.7.2.4.3.  Phase 2

13.7.2.4.4.  Phase 3

13.7.2.4.5.  Phase 4

13.7.2.4.6.  Commercial

13.7.2.5.  Canada Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

13.7.2.5.1.  Commercial Production

13.7.2.5.1.1. Small scale

13.7.2.5.1.2. Large Scale

13.7.2.5.2.  Clinical Production

13.7.2.5.3.  Aseptic Filling

13.7.2.5.4.  Others

13.7.3. Mexico

13.7.3.1.  Mexico Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

13.7.3.1.1.  Drug discovery

13.7.3.1.2.  Drug manufacturing and commercial production

13.7.3.1.3.  Documentation of compliance with FDA regulatory requirements

13.7.3.1.4.  Pre-formulation

13.7.3.1.5.  Providing late-stage clinical trial materials

13.7.3.1.6.  Providing formal stability, scale-up, registration batches

13.7.3.1.7.  API manufacturing

13.7.3.1.8.  Others

13.7.3.2.  Mexico Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

13.7.3.2.1.  Autoimmune Diseases

13.7.3.2.2.  Oncology

13.7.3.2.3.  Metabolic Diseases

13.7.3.2.4.  Ophthalmology

13.7.3.2.5.  Cardiovascular Diseases

13.7.3.2.6.  Infectious Diseases

13.7.3.2.7.  Neurology

13.7.3.2.8.  Respiratory Disorders

13.7.3.2.9.  Others

13.7.3.3.  Mexico Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

13.7.3.3.1.  Solid

13.7.3.3.1.1. Tablets and Capsules

13.7.3.3.1.2. Compressed tablets

13.7.3.3.1.3. Micro and mini tablets

13.7.3.3.1.4. Aqueous film coated tablets

13.7.3.3.1.5. Others

13.7.3.3.2.  Liquid

13.7.3.3.2.1. Oral Solutions

13.7.3.3.2.2. Topical Solutions

13.7.3.3.3.  Semi-solid

13.7.3.3.3.1. Creams

13.7.3.3.3.2. Gels

13.7.3.3.3.3. Ointments

13.7.3.3.3.4. Others

13.7.3.4.  Mexico Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

13.7.3.4.1.  Preclinical

13.7.3.4.2.  Phase 1

13.7.3.4.3.  Phase 2

13.7.3.4.4.  Phase 3

13.7.3.4.5.  Phase 4

13.7.3.4.6.  Commercial

13.7.3.5.  Mexico Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

13.7.3.5.1.  Commercial Production

13.7.3.5.1.1. Small scale

13.7.3.5.1.2. Large Scale

13.7.3.5.2.  Clinical Production

13.7.3.5.3.  Aseptic Filling

13.7.3.5.4.  Others

13.7.4. Rest of North America

13.7.4.1.  Rest of North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

13.7.4.1.1.  Drug discovery

13.7.4.1.2.  Drug manufacturing and commercial production

13.7.4.1.3.  Documentation of compliance with FDA regulatory requirements

13.7.4.1.4.  Pre-formulation

13.7.4.1.5.  Providing late-stage clinical trial materials

13.7.4.1.6.  Providing formal stability, scale-up, registration batches

13.7.4.1.7.  API manufacturing

13.7.4.1.8.  Others

13.7.4.2.  Rest of North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

13.7.4.2.1.  Autoimmune Diseases

13.7.4.2.2.  Oncology

13.7.4.2.3.  Metabolic Diseases

13.7.4.2.4.  Ophthalmology

13.7.4.2.5.  Cardiovascular Diseases

13.7.4.2.6.  Infectious Diseases

13.7.4.2.7.  Neurology

13.7.4.2.8.  Respiratory Disorders

13.7.4.2.9.  Others

13.7.4.3.  Rest of North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

13.7.4.3.1.  Solid

13.7.4.3.1.1. Tablets and Capsules

13.7.4.3.1.2. Compressed tablets

13.7.4.3.1.3. Micro and mini tablets

13.7.4.3.1.4. Aqueous film coated tablets

13.7.4.3.1.5. Others

13.7.4.3.2.  Liquid

13.7.4.3.2.1. Oral Solutions

13.7.4.3.2.2. Topical Solutions

13.7.4.3.3.  Semi-solid

13.7.4.3.3.1. Creams

13.7.4.3.3.2. Gels

13.7.4.3.3.3. Ointments

13.7.4.3.3.4. Others

13.7.4.4.  Rest of North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

13.7.4.4.1.  Preclinical

13.7.4.4.2.  Phase 1

13.7.4.4.3.  Phase 2

13.7.4.4.4.  Phase 3

13.7.4.4.5.  Phase 4

13.7.4.4.6.  Commercial

13.7.4.5.  Rest of North America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

13.7.4.5.1.  Commercial Production

13.7.4.5.1.1. Small scale

13.7.4.5.1.2. Large Scale

13.7.4.5.2.  Clinical Production

13.7.4.5.3.  Aseptic Filling

13.7.4.5.4.  Others

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Service

13.8.3. By Therapeutic Area

13.8.4. By Form

13.8.5. By Clinical Phase

13.8.6. By Process

14. Europe Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

14.1. Overview

14.1.1. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

14.2. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.2.1. Drug discovery

14.2.2. Drug manufacturing and commercial production

14.2.3. Documentation of compliance with FDA regulatory requirements

14.2.4. Pre-formulation

14.2.5. Providing late-stage clinical trial materials

14.2.6. Providing formal stability, scale-up, registration batches

14.2.7. API manufacturing

14.2.8. Others

14.3. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.3.1. Autoimmune Diseases

14.3.2. Oncology

14.3.3. Metabolic Diseases

14.3.4. Ophthalmology

14.3.5. Cardiovascular Diseases

14.3.6. Infectious Diseases

14.3.7. Neurology

14.3.8. Respiratory Disorders

14.3.9. Others

14.4. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.4.1. Solid

14.4.1.1.  Tablets and Capsules

14.4.1.2.  Compressed tablets

14.4.1.3.  Micro and mini tablets

14.4.1.4.  Aqueous film coated tablets

14.4.1.5.  Others

14.4.2. Liquid

14.4.2.1.  Oral Solutions

14.4.2.2.  Topical Solutions

14.4.3. Semi-solid

14.4.3.1.  Creams

14.4.3.2.  Gels

14.4.3.3.  Ointments

14.4.3.4.  Others

14.5. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.5.1. Preclinical

14.5.2. Phase 1

14.5.3. Phase 2

14.5.4. Phase 3

14.5.5. Phase 4

14.5.6. Commercial

14.6. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.6.1. Commercial Production

14.6.1.1.  Small scale

14.6.1.2.  Large Scale

14.6.2. Clinical Production

14.6.3. Aseptic Filling

14.6.4. Others

14.7. Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1.  France Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.1.1.1.  Drug discovery

14.7.1.1.2.  Drug manufacturing and commercial production

14.7.1.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.1.1.4.  Pre-formulation

14.7.1.1.5.  Providing late-stage clinical trial materials

14.7.1.1.6.  Providing formal stability, scale-up, registration batches

14.7.1.1.7.  API manufacturing

14.7.1.1.8.  Others

14.7.1.2.  France Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.1.2.1.  Autoimmune Diseases

14.7.1.2.2.  Oncology

14.7.1.2.3.  Metabolic Diseases

14.7.1.2.4.  Ophthalmology

14.7.1.2.5.  Cardiovascular Diseases

14.7.1.2.6.  Infectious Diseases

14.7.1.2.7.  Neurology

14.7.1.2.8.  Respiratory Disorders

14.7.1.2.9.  Others

14.7.1.3.  France Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.1.3.1.  Solid

14.7.1.3.1.1. Tablets and Capsules

14.7.1.3.1.2. Compressed tablets

14.7.1.3.1.3. Micro and mini tablets

14.7.1.3.1.4. Aqueous film coated tablets

14.7.1.3.1.5. Others

14.7.1.3.2.  Liquid

14.7.1.3.2.1. Oral Solutions

14.7.1.3.2.2. Topical Solutions

14.7.1.3.3.  Semi-solid

14.7.1.3.3.1. Creams

14.7.1.3.3.2. Gels

14.7.1.3.3.3. Ointments

14.7.1.3.3.4. Others

14.7.1.4.  France Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.1.4.1.  Preclinical

14.7.1.4.2.  Phase 1

14.7.1.4.3.  Phase 2

14.7.1.4.4.  Phase 3

14.7.1.4.5.  Phase 4

14.7.1.4.6.  Commercial

14.7.1.5.  France Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.1.5.1.  Commercial Production

14.7.1.5.1.1. Small scale

14.7.1.5.1.2. Large Scale

14.7.1.5.2.  Clinical Production

14.7.1.5.3.  Aseptic Filling

14.7.1.5.4.  Others

14.7.2. The UK

14.7.2.1.  The UK Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.2.1.1.  Drug discovery

14.7.2.1.2.  Drug manufacturing and commercial production

14.7.2.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.2.1.4.  Pre-formulation

14.7.2.1.5.  Providing late-stage clinical trial materials

14.7.2.1.6.  Providing formal stability, scale-up, registration batches

14.7.2.1.7.  API manufacturing

14.7.2.1.8.  Others

14.7.2.2.  The UK Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.2.2.1.  Autoimmune Diseases

14.7.2.2.2.  Oncology

14.7.2.2.3.  Metabolic Diseases

14.7.2.2.4.  Ophthalmology

14.7.2.2.5.  Cardiovascular Diseases

14.7.2.2.6.  Infectious Diseases

14.7.2.2.7.  Neurology

14.7.2.2.8.  Respiratory Disorders

14.7.2.2.9.  Others

14.7.2.3.  The UK Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.2.3.1.  Solid

14.7.2.3.1.1. Tablets and Capsules

14.7.2.3.1.2. Compressed tablets

14.7.2.3.1.3. Micro and mini tablets

14.7.2.3.1.4. Aqueous film coated tablets

14.7.2.3.1.5. Others

14.7.2.3.2.  Liquid

14.7.2.3.2.1. Oral Solutions

14.7.2.3.2.2. Topical Solutions

14.7.2.3.3.  Semi-solid

14.7.2.3.3.1. Creams

14.7.2.3.3.2. Gels

14.7.2.3.3.3. Ointments

14.7.2.3.3.4. Others

14.7.2.4.  The UK Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.2.4.1.  Preclinical

14.7.2.4.2.  Phase 1

14.7.2.4.3.  Phase 2

14.7.2.4.4.  Phase 3

14.7.2.4.5.  Phase 4

14.7.2.4.6.  Commercial

14.7.2.5.  The UK Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.2.5.1.  Commercial Production

14.7.2.5.1.1. Small scale

14.7.2.5.1.2. Large Scale

14.7.2.5.2.  Clinical Production

14.7.2.5.3.  Aseptic Filling

14.7.2.5.4.  Others

14.7.3. Spain

14.7.3.1.  Spain Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.3.1.1.  Drug discovery

14.7.3.1.2.  Drug manufacturing and commercial production

14.7.3.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.3.1.4.  Pre-formulation

14.7.3.1.5.  Providing late-stage clinical trial materials

14.7.3.1.6.  Providing formal stability, scale-up, registration batches

14.7.3.1.7.  API manufacturing

14.7.3.1.8.  Others

14.7.3.2.  Spain Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.3.2.1.  Autoimmune Diseases

14.7.3.2.2.  Oncology

14.7.3.2.3.  Metabolic Diseases

14.7.3.2.4.  Ophthalmology

14.7.3.2.5.  Cardiovascular Diseases

14.7.3.2.6.  Infectious Diseases

14.7.3.2.7.  Neurology

14.7.3.2.8.  Respiratory Disorders

14.7.3.2.9.  Others

14.7.3.3.  Spain Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.3.3.1.  Solid

14.7.3.3.1.1. Tablets and Capsules

14.7.3.3.1.2. Compressed tablets

14.7.3.3.1.3. Micro and mini tablets

14.7.3.3.1.4. Aqueous film coated tablets

14.7.3.3.1.5. Others

14.7.3.3.2.  Liquid

14.7.3.3.2.1. Oral Solutions

14.7.3.3.2.2. Topical Solutions

14.7.3.3.3.  Semi-solid

14.7.3.3.3.1. Creams

14.7.3.3.3.2. Gels

14.7.3.3.3.3. Ointments

14.7.3.3.3.4. Others

14.7.3.4.  Spain Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.3.4.1.  Preclinical

14.7.3.4.2.  Phase 1

14.7.3.4.3.  Phase 2

14.7.3.4.4.  Phase 3

14.7.3.4.5.  Phase 4

14.7.3.4.6.  Commercial

14.7.3.5.  Spain Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.3.5.1.  Commercial Production

14.7.3.5.1.1. Small scale

14.7.3.5.1.2. Large Scale

14.7.3.5.2.  Clinical Production

14.7.3.5.3.  Aseptic Filling

14.7.3.5.4.  Others

14.7.4. Germany

14.7.4.1.  Germany Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.4.1.1.  Drug discovery

14.7.4.1.2.  Drug manufacturing and commercial production

14.7.4.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.4.1.4.  Pre-formulation

14.7.4.1.5.  Providing late-stage clinical trial materials

14.7.4.1.6.  Providing formal stability, scale-up, registration batches

14.7.4.1.7.  API manufacturing

14.7.4.1.8.  Others

14.7.4.2.  Germany Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.4.2.1.  Autoimmune Diseases

14.7.4.2.2.  Oncology

14.7.4.2.3.  Metabolic Diseases

14.7.4.2.4.  Ophthalmology

14.7.4.2.5.  Cardiovascular Diseases

14.7.4.2.6.  Infectious Diseases

14.7.4.2.7.  Neurology

14.7.4.2.8.  Respiratory Disorders

14.7.4.2.9.  Others

14.7.4.3.  Germany Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.4.3.1.  Solid

14.7.4.3.1.1. Tablets and Capsules

14.7.4.3.1.2. Compressed tablets

14.7.4.3.1.3. Micro and mini tablets

14.7.4.3.1.4. Aqueous film coated tablets

14.7.4.3.1.5. Others

14.7.4.3.2.  Liquid

14.7.4.3.2.1. Oral Solutions

14.7.4.3.2.2. Topical Solutions

14.7.4.3.3.  Semi-solid

14.7.4.3.3.1. Creams

14.7.4.3.3.2. Gels

14.7.4.3.3.3. Ointments

14.7.4.3.3.4. Others

14.7.4.4.  Germany Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.4.4.1.  Preclinical

14.7.4.4.2.  Phase 1

14.7.4.4.3.  Phase 2

14.7.4.4.4.  Phase 3

14.7.4.4.5.  Phase 4

14.7.4.4.6.  Commercial

14.7.4.5.  Germany Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.4.5.1.  Commercial Production

14.7.4.5.1.1. Small scale

14.7.4.5.1.2. Large Scale

14.7.4.5.2.  Clinical Production

14.7.4.5.3.  Aseptic Filling

14.7.4.5.4.  Others

14.7.5. Italy

14.7.5.1.  Italy Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.5.1.1.  Drug discovery

14.7.5.1.2.  Drug manufacturing and commercial production

14.7.5.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.5.1.4.  Pre-formulation

14.7.5.1.5.  Providing late-stage clinical trial materials

14.7.5.1.6.  Providing formal stability, scale-up, registration batches

14.7.5.1.7.  API manufacturing

14.7.5.1.8.  Others

14.7.5.2.  Italy Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.5.2.1.  Autoimmune Diseases

14.7.5.2.2.  Oncology

14.7.5.2.3.  Metabolic Diseases

14.7.5.2.4.  Ophthalmology

14.7.5.2.5.  Cardiovascular Diseases

14.7.5.2.6.  Infectious Diseases

14.7.5.2.7.  Neurology

14.7.5.2.8.  Respiratory Disorders

14.7.5.2.9.  Others

14.7.5.3.  Italy Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.5.3.1.  Solid

14.7.5.3.1.1. Tablets and Capsules

14.7.5.3.1.2. Compressed tablets

14.7.5.3.1.3. Micro and mini tablets

14.7.5.3.1.4. Aqueous film coated tablets

14.7.5.3.1.5. Others

14.7.5.3.2.  Liquid

14.7.5.3.2.1. Oral Solutions

14.7.5.3.2.2. Topical Solutions

14.7.5.3.3.  Semi-solid

14.7.5.3.3.1. Creams

14.7.5.3.3.2. Gels

14.7.5.3.3.3. Ointments

14.7.5.3.3.4. Others

14.7.5.4.  Italy Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.5.4.1.  Preclinical

14.7.5.4.2.  Phase 1

14.7.5.4.3.  Phase 2

14.7.5.4.4.  Phase 3

14.7.5.4.5.  Phase 4

14.7.5.4.6.  Commercial

14.7.5.5.  Italy Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.5.5.1.  Commercial Production

14.7.5.5.1.1. Small scale

14.7.5.5.1.2. Large Scale

14.7.5.5.2.  Clinical Production

14.7.5.5.3.  Aseptic Filling

14.7.5.5.4.  Others

14.7.6. Nordic Countries

14.7.6.1.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.6.1.1.  Drug discovery

14.7.6.1.2.  Drug manufacturing and commercial production

14.7.6.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.6.1.4.  Pre-formulation

14.7.6.1.5.  Providing late-stage clinical trial materials

14.7.6.1.6.  Providing formal stability, scale-up, registration batches

14.7.6.1.7.  API manufacturing

14.7.6.1.8.  Others

14.7.6.2.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.6.2.1.  Autoimmune Diseases

14.7.6.2.2.  Oncology

14.7.6.2.3.  Metabolic Diseases

14.7.6.2.4.  Ophthalmology

14.7.6.2.5.  Cardiovascular Diseases

14.7.6.2.6.  Infectious Diseases

14.7.6.2.7.  Neurology

14.7.6.2.8.  Respiratory Disorders

14.7.6.2.9.  Others

14.7.6.3.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.6.3.1.  Solid

14.7.6.3.1.1. Tablets and Capsules

14.7.6.3.1.2. Compressed tablets

14.7.6.3.1.3. Micro and mini tablets

14.7.6.3.1.4. Aqueous film coated tablets

14.7.6.3.1.5. Others

14.7.6.3.2.  Liquid

14.7.6.3.2.1. Oral Solutions

14.7.6.3.2.2. Topical Solutions

14.7.6.3.3.  Semi-solid

14.7.6.3.3.1. Creams

14.7.6.3.3.2. Gels

14.7.6.3.3.3. Ointments

14.7.6.3.3.4. Others

14.7.6.4.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.6.4.1.  Preclinical

14.7.6.4.2.  Phase 1

14.7.6.4.3.  Phase 2

14.7.6.4.4.  Phase 3

14.7.6.4.5.  Phase 4

14.7.6.4.6.  Commercial

14.7.6.5.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.6.5.1.  Commercial Production

14.7.6.5.1.1. Small scale

14.7.6.5.1.2. Large Scale

14.7.6.5.2.  Clinical Production

14.7.6.5.3.  Aseptic Filling

14.7.6.5.4.  Others

14.7.6.6.  Nordic Countries Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1.  Denmark

14.7.6.6.2.  Finland

14.7.6.6.3.  Iceland

14.7.6.6.4.  Sweden

14.7.6.6.5.  Norway

14.7.7. Benelux Union

14.7.7.1.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.7.1.1.  Drug discovery

14.7.7.1.2.  Drug manufacturing and commercial production

14.7.7.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.7.1.4.  Pre-formulation

14.7.7.1.5.  Providing late-stage clinical trial materials

14.7.7.1.6.  Providing formal stability, scale-up, registration batches

14.7.7.1.7.  API manufacturing

14.7.7.1.8.  Others

14.7.7.2.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.7.2.1.  Autoimmune Diseases

14.7.7.2.2.  Oncology

14.7.7.2.3.  Metabolic Diseases

14.7.7.2.4.  Ophthalmology

14.7.7.2.5.  Cardiovascular Diseases

14.7.7.2.6.  Infectious Diseases

14.7.7.2.7.  Neurology

14.7.7.2.8.  Respiratory Disorders

14.7.7.2.9.  Others

14.7.7.3.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.7.3.1.  Solid

14.7.7.3.1.1. Tablets and Capsules

14.7.7.3.1.2. Compressed tablets

14.7.7.3.1.3. Micro and mini tablets

14.7.7.3.1.4. Aqueous film coated tablets

14.7.7.3.1.5. Others

14.7.7.3.2.  Liquid

14.7.7.3.2.1. Oral Solutions

14.7.7.3.2.2. Topical Solutions

14.7.7.3.3.  Semi-solid

14.7.7.3.3.1. Creams

14.7.7.3.3.2. Gels

14.7.7.3.3.3. Ointments

14.7.7.3.3.4. Others

14.7.7.4.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.7.4.1.  Preclinical

14.7.7.4.2.  Phase 1

14.7.7.4.3.  Phase 2

14.7.7.4.4.  Phase 3

14.7.7.4.5.  Phase 4

14.7.7.4.6.  Commercial

14.7.7.5.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.7.5.1.  Commercial Production

14.7.7.5.1.1. Small scale

14.7.7.5.1.2. Large Scale

14.7.7.5.2.  Clinical Production

14.7.7.5.3.  Aseptic Filling

14.7.7.5.4.  Others

14.7.7.6.  Benelux Union Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1.  Belgium

14.7.7.6.2.  The Netherlands

14.7.7.6.3.  Luxembourg

14.7.8. Rest of Europe

14.7.8.1.  Rest of Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

14.7.8.1.1.  Drug discovery

14.7.8.1.2.  Drug manufacturing and commercial production

14.7.8.1.3.  Documentation of compliance with FDA regulatory requirements

14.7.8.1.4.  Pre-formulation

14.7.8.1.5.  Providing late-stage clinical trial materials

14.7.8.1.6.  Providing formal stability, scale-up, registration batches

14.7.8.1.7.  API manufacturing

14.7.8.1.8.  Others

14.7.8.2.  Rest of Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

14.7.8.2.1.  Autoimmune Diseases

14.7.8.2.2.  Oncology

14.7.8.2.3.  Metabolic Diseases

14.7.8.2.4.  Ophthalmology

14.7.8.2.5.  Cardiovascular Diseases

14.7.8.2.6.  Infectious Diseases

14.7.8.2.7.  Neurology

14.7.8.2.8.  Respiratory Disorders

14.7.8.2.9.  Others

14.7.8.3.  Rest of Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

14.7.8.3.1.  Solid

14.7.8.3.1.1. Tablets and Capsules

14.7.8.3.1.2. Compressed tablets

14.7.8.3.1.3. Micro and mini tablets

14.7.8.3.1.4. Aqueous film coated tablets

14.7.8.3.1.5. Others

14.7.8.3.2.  Liquid

14.7.8.3.2.1. Oral Solutions

14.7.8.3.2.2. Topical Solutions

14.7.8.3.3.  Semi-solid

14.7.8.3.3.1. Creams

14.7.8.3.3.2. Gels

14.7.8.3.3.3. Ointments

14.7.8.3.3.4. Others

14.7.8.4.  Rest of Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

14.7.8.4.1.  Preclinical

14.7.8.4.2.  Phase 1

14.7.8.4.3.  Phase 2

14.7.8.4.4.  Phase 3

14.7.8.4.5.  Phase 4

14.7.8.4.6.  Commercial

14.7.8.5.  Rest of Europe Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

14.7.8.5.1.  Commercial Production

14.7.8.5.1.1. Small scale

14.7.8.5.1.2. Large Scale

14.7.8.5.2.  Clinical Production

14.7.8.5.3.  Aseptic Filling

14.7.8.5.4.  Others

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Service

14.8.3. By Therapeutic Area

14.8.4. By Form

14.8.5. By Clinical Phase

14.8.6. By Process

15. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

15.1. Overview

15.1.1. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

15.2. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.2.1. Drug discovery

15.2.2. Drug manufacturing and commercial production

15.2.3. Documentation of compliance with FDA regulatory requirements

15.2.4. Pre-formulation

15.2.5. Providing late-stage clinical trial materials

15.2.6. Providing formal stability, scale-up, registration batches

15.2.7. API manufacturing

15.2.8. Others

15.3. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.3.1. Autoimmune Diseases

15.3.2. Oncology

15.3.3. Metabolic Diseases

15.3.4. Ophthalmology

15.3.5. Cardiovascular Diseases

15.3.6. Infectious Diseases

15.3.7. Neurology

15.3.8. Respiratory Disorders

15.3.9. Others

15.4. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.4.1. Solid

15.4.1.1.  Tablets and Capsules

15.4.1.2.  Compressed tablets

15.4.1.3.  Micro and mini tablets

15.4.1.4.  Aqueous film coated tablets

15.4.1.5.  Others

15.4.2. Liquid

15.4.2.1.  Oral Solutions

15.4.2.2.  Topical Solutions

15.4.3. Semi-solid

15.4.3.1.  Creams

15.4.3.2.  Gels

15.4.3.3.  Ointments

15.4.3.4.  Others

15.5. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.5.1. Preclinical

15.5.2. Phase 1

15.5.3. Phase 2

15.5.4. Phase 3

15.5.5. Phase 4

15.5.6. Commercial

15.6. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.6.1. Commercial Production

15.6.1.1.  Small scale

15.6.1.2.  Large Scale

15.6.2. Clinical Production

15.6.3. Aseptic Filling

15.6.4. Others

15.7. Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1.  China Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.1.1.1.  Drug discovery

15.7.1.1.2.  Drug manufacturing and commercial production

15.7.1.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.1.1.4.  Pre-formulation

15.7.1.1.5.  Providing late-stage clinical trial materials

15.7.1.1.6.  Providing formal stability, scale-up, registration batches

15.7.1.1.7.  API manufacturing

15.7.1.1.8.  Others

15.7.1.2.  China Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.1.2.1.  Autoimmune Diseases

15.7.1.2.2.  Oncology

15.7.1.2.3.  Metabolic Diseases

15.7.1.2.4.  Ophthalmology

15.7.1.2.5.  Cardiovascular Diseases

15.7.1.2.6.  Infectious Diseases

15.7.1.2.7.  Neurology

15.7.1.2.8.  Respiratory Disorders

15.7.1.2.9.  Others

15.7.1.3.  China Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.1.3.1.  Solid

15.7.1.3.1.1. Tablets and Capsules

15.7.1.3.1.2. Compressed tablets

15.7.1.3.1.3. Micro and mini tablets

15.7.1.3.1.4. Aqueous film coated tablets

15.7.1.3.1.5. Others

15.7.1.3.2.  Liquid

15.7.1.3.2.1. Oral Solutions

15.7.1.3.2.2. Topical Solutions

15.7.1.3.3.  Semi-solid

15.7.1.3.3.1. Creams

15.7.1.3.3.2. Gels

15.7.1.3.3.3. Ointments

15.7.1.3.3.4. Others

15.7.1.4.  China Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.1.4.1.  Preclinical

15.7.1.4.2.  Phase 1

15.7.1.4.3.  Phase 2

15.7.1.4.4.  Phase 3

15.7.1.4.5.  Phase 4

15.7.1.4.6.  Commercial

15.7.1.5.  China Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.1.5.1.  Commercial Production

15.7.1.5.1.1. Small scale

15.7.1.5.1.2. Large Scale

15.7.1.5.2.  Clinical Production

15.7.1.5.3.  Aseptic Filling

15.7.1.5.4.  Others

15.7.2. Japan

15.7.2.1.  Japan Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.2.1.1.  Drug discovery

15.7.2.1.2.  Drug manufacturing and commercial production

15.7.2.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.2.1.4.  Pre-formulation

15.7.2.1.5.  Providing late-stage clinical trial materials

15.7.2.1.6.  Providing formal stability, scale-up, registration batches

15.7.2.1.7.  API manufacturing

15.7.2.1.8.  Others

15.7.2.2.  Japan Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.2.2.1.  Autoimmune Diseases

15.7.2.2.2.  Oncology

15.7.2.2.3.  Metabolic Diseases

15.7.2.2.4.  Ophthalmology

15.7.2.2.5.  Cardiovascular Diseases

15.7.2.2.6.  Infectious Diseases

15.7.2.2.7.  Neurology

15.7.2.2.8.  Respiratory Disorders

15.7.2.2.9.  Others

15.7.2.3.  Japan Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.2.3.1.  Solid

15.7.2.3.1.1. Tablets and Capsules

15.7.2.3.1.2. Compressed tablets

15.7.2.3.1.3. Micro and mini tablets

15.7.2.3.1.4. Aqueous film coated tablets

15.7.2.3.1.5. Others

15.7.2.3.2.  Liquid

15.7.2.3.2.1. Oral Solutions

15.7.2.3.2.2. Topical Solutions

15.7.2.3.3.  Semi-solid

15.7.2.3.3.1. Creams

15.7.2.3.3.2. Gels

15.7.2.3.3.3. Ointments

15.7.2.3.3.4. Others

15.7.2.4.  Japan Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.2.4.1.  Preclinical

15.7.2.4.2.  Phase 1

15.7.2.4.3.  Phase 2

15.7.2.4.4.  Phase 3

15.7.2.4.5.  Phase 4

15.7.2.4.6.  Commercial

15.7.2.5.  Japan Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.2.5.1.  Commercial Production

15.7.2.5.1.1. Small scale

15.7.2.5.1.2. Large Scale

15.7.2.5.2.  Clinical Production

15.7.2.5.3.  Aseptic Filling

15.7.2.5.4.  Others

15.7.3. India

15.7.3.1.  India Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.3.1.1.  Drug discovery

15.7.3.1.2.  Drug manufacturing and commercial production

15.7.3.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.3.1.4.  Pre-formulation

15.7.3.1.5.  Providing late-stage clinical trial materials

15.7.3.1.6.  Providing formal stability, scale-up, registration batches

15.7.3.1.7.  API manufacturing

15.7.3.1.8.  Others

15.7.3.2.  India Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.3.2.1.  Autoimmune Diseases

15.7.3.2.2.  Oncology

15.7.3.2.3.  Metabolic Diseases

15.7.3.2.4.  Ophthalmology

15.7.3.2.5.  Cardiovascular Diseases

15.7.3.2.6.  Infectious Diseases

15.7.3.2.7.  Neurology

15.7.3.2.8.  Respiratory Disorders

15.7.3.2.9.  Others

15.7.3.3.  India Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.3.3.1.  Solid

15.7.3.3.1.1. Tablets and Capsules

15.7.3.3.1.2. Compressed tablets

15.7.3.3.1.3. Micro and mini tablets

15.7.3.3.1.4. Aqueous film coated tablets

15.7.3.3.1.5. Others

15.7.3.3.2.  Liquid

15.7.3.3.2.1. Oral Solutions

15.7.3.3.2.2. Topical Solutions

15.7.3.3.3.  Semi-solid

15.7.3.3.3.1. Creams

15.7.3.3.3.2. Gels

15.7.3.3.3.3. Ointments

15.7.3.3.3.4. Others

15.7.3.4.  India Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.3.4.1.  Preclinical

15.7.3.4.2.  Phase 1

15.7.3.4.3.  Phase 2

15.7.3.4.4.  Phase 3

15.7.3.4.5.  Phase 4

15.7.3.4.6.  Commercial

15.7.3.5.  India Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.3.5.1.  Commercial Production

15.7.3.5.1.1. Small scale

15.7.3.5.1.2. Large Scale

15.7.3.5.2.  Clinical Production

15.7.3.5.3.  Aseptic Filling

15.7.3.5.4.  Others

15.7.4. New Zealand

15.7.4.1.  New Zealand Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.4.1.1.  Drug discovery

15.7.4.1.2.  Drug manufacturing and commercial production

15.7.4.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.4.1.4.  Pre-formulation

15.7.4.1.5.  Providing late-stage clinical trial materials

15.7.4.1.6.  Providing formal stability, scale-up, registration batches

15.7.4.1.7.  API manufacturing

15.7.4.1.8.  Others

15.7.4.2.  New Zealand Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.4.2.1.  Autoimmune Diseases

15.7.4.2.2.  Oncology

15.7.4.2.3.  Metabolic Diseases

15.7.4.2.4.  Ophthalmology

15.7.4.2.5.  Cardiovascular Diseases

15.7.4.2.6.  Infectious Diseases

15.7.4.2.7.  Neurology

15.7.4.2.8.  Respiratory Disorders

15.7.4.2.9.  Others

15.7.4.3.  New Zealand Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.4.3.1.  Solid

15.7.4.3.1.1. Tablets and Capsules

15.7.4.3.1.2. Compressed tablets

15.7.4.3.1.3. Micro and mini tablets

15.7.4.3.1.4. Aqueous film coated tablets

15.7.4.3.1.5. Others

15.7.4.3.2.  Liquid

15.7.4.3.2.1. Oral Solutions

15.7.4.3.2.2. Topical Solutions

15.7.4.3.3.  Semi-solid

15.7.4.3.3.1. Creams

15.7.4.3.3.2. Gels

15.7.4.3.3.3. Ointments

15.7.4.3.3.4. Others

15.7.4.4.  New Zealand Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.4.4.1.  Preclinical

15.7.4.4.2.  Phase 1

15.7.4.4.3.  Phase 2

15.7.4.4.4.  Phase 3

15.7.4.4.5.  Phase 4

15.7.4.4.6.  Commercial

15.7.4.5.  New Zealand Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.4.5.1.  Commercial Production

15.7.4.5.1.1. Small scale

15.7.4.5.1.2. Large Scale

15.7.4.5.2.  Clinical Production

15.7.4.5.3.  Aseptic Filling

15.7.4.5.4.  Others

15.7.5. Australia

15.7.5.1.  Australia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.5.1.1.  Drug discovery

15.7.5.1.2.  Drug manufacturing and commercial production

15.7.5.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.5.1.4.  Pre-formulation

15.7.5.1.5.  Providing late-stage clinical trial materials

15.7.5.1.6.  Providing formal stability, scale-up, registration batches

15.7.5.1.7.  API manufacturing

15.7.5.1.8.  Others

15.7.5.2.  Australia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.5.2.1.  Autoimmune Diseases

15.7.5.2.2.  Oncology

15.7.5.2.3.  Metabolic Diseases

15.7.5.2.4.  Ophthalmology

15.7.5.2.5.  Cardiovascular Diseases

15.7.5.2.6.  Infectious Diseases

15.7.5.2.7.  Neurology

15.7.5.2.8.  Respiratory Disorders

15.7.5.2.9.  Others

15.7.5.3.  Australia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.5.3.1.  Solid

15.7.5.3.1.1. Tablets and Capsules

15.7.5.3.1.2. Compressed tablets

15.7.5.3.1.3. Micro and mini tablets

15.7.5.3.1.4. Aqueous film coated tablets

15.7.5.3.1.5. Others

15.7.5.3.2.  Liquid

15.7.5.3.2.1. Oral Solutions

15.7.5.3.2.2. Topical Solutions

15.7.5.3.3.  Semi-solid

15.7.5.3.3.1. Creams

15.7.5.3.3.2. Gels

15.7.5.3.3.3. Ointments

15.7.5.3.3.4. Others

15.7.5.4.  Australia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.5.4.1.  Preclinical

15.7.5.4.2.  Phase 1

15.7.5.4.3.  Phase 2

15.7.5.4.4.  Phase 3

15.7.5.4.5.  Phase 4

15.7.5.4.6.  Commercial

15.7.5.5.  Australia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.5.5.1.  Commercial Production

15.7.5.5.1.1. Small scale

15.7.5.5.1.2. Large Scale

15.7.5.5.2.  Clinical Production

15.7.5.5.3.  Aseptic Filling

15.7.5.5.4.  Others

15.7.6. South Korea

15.7.6.1.  South Korea Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.6.1.1.  Drug discovery

15.7.6.1.2.  Drug manufacturing and commercial production

15.7.6.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.6.1.4.  Pre-formulation

15.7.6.1.5.  Providing late-stage clinical trial materials

15.7.6.1.6.  Providing formal stability, scale-up, registration batches

15.7.6.1.7.  API manufacturing

15.7.6.1.8.  Others

15.7.6.2.  South Korea Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.6.2.1.  Autoimmune Diseases

15.7.6.2.2.  Oncology

15.7.6.2.3.  Metabolic Diseases

15.7.6.2.4.  Ophthalmology

15.7.6.2.5.  Cardiovascular Diseases

15.7.6.2.6.  Infectious Diseases

15.7.6.2.7.  Neurology

15.7.6.2.8.  Respiratory Disorders

15.7.6.2.9.  Others

15.7.6.3.  South Korea Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.6.3.1.  Solid

15.7.6.3.1.1. Tablets and Capsules

15.7.6.3.1.2. Compressed tablets

15.7.6.3.1.3. Micro and mini tablets

15.7.6.3.1.4. Aqueous film coated tablets

15.7.6.3.1.5. Others

15.7.6.3.2.  Liquid

15.7.6.3.2.1. Oral Solutions

15.7.6.3.2.2. Topical Solutions

15.7.6.3.3.  Semi-solid

15.7.6.3.3.1. Creams

15.7.6.3.3.2. Gels

15.7.6.3.3.3. Ointments

15.7.6.3.3.4. Others

15.7.6.4.  South Korea Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.6.4.1.  Preclinical

15.7.6.4.2.  Phase 1

15.7.6.4.3.  Phase 2

15.7.6.4.4.  Phase 3

15.7.6.4.5.  Phase 4

15.7.6.4.6.  Commercial

15.7.6.5.  South Korea Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.6.5.1.  Commercial Production

15.7.6.5.1.1. Small scale

15.7.6.5.1.2. Large Scale

15.7.6.5.2.  Clinical Production

15.7.6.5.3.  Aseptic Filling

15.7.6.5.4.  Others

15.7.7. Southeast Asia

15.7.7.1.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.7.1.1.  Drug discovery

15.7.7.1.2.  Drug manufacturing and commercial production

15.7.7.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.7.1.4.  Pre-formulation

15.7.7.1.5.  Providing late-stage clinical trial materials

15.7.7.1.6.  Providing formal stability, scale-up, registration batches

15.7.7.1.7.  API manufacturing

15.7.7.1.8.  Others

15.7.7.2.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.7.2.1.  Autoimmune Diseases

15.7.7.2.2.  Oncology

15.7.7.2.3.  Metabolic Diseases

15.7.7.2.4.  Ophthalmology

15.7.7.2.5.  Cardiovascular Diseases

15.7.7.2.6.  Infectious Diseases

15.7.7.2.7.  Neurology

15.7.7.2.8.  Respiratory Disorders

15.7.7.2.9.  Others

15.7.7.3.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.7.3.1.  Solid

15.7.7.3.1.1. Tablets and Capsules

15.7.7.3.1.2. Compressed tablets

15.7.7.3.1.3. Micro and mini tablets

15.7.7.3.1.4. Aqueous film coated tablets

15.7.7.3.1.5. Others

15.7.7.3.2.  Liquid

15.7.7.3.2.1. Oral Solutions

15.7.7.3.2.2. Topical Solutions

15.7.7.3.3.  Semi-solid

15.7.7.3.3.1. Creams

15.7.7.3.3.2. Gels

15.7.7.3.3.3. Ointments

15.7.7.3.3.4. Others

15.7.7.4.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.7.4.1.  Preclinical

15.7.7.4.2.  Phase 1

15.7.7.4.3.  Phase 2

15.7.7.4.4.  Phase 3

15.7.7.4.5.  Phase 4

15.7.7.4.6.  Commercial

15.7.7.5.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.7.5.1.  Commercial Production

15.7.7.5.1.1. Small scale

15.7.7.5.1.2. Large Scale

15.7.7.5.2.  Clinical Production

15.7.7.5.3.  Aseptic Filling

15.7.7.5.4.  Others

15.7.7.6.  Southeast Asia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1.  Indonesia

15.7.7.6.2.  Thailand

15.7.7.6.3.  Malaysia

15.7.7.6.4.  Singapore

15.7.7.6.5.  Rest of Southeast Asia

15.7.8. Rest of Asia Pacific

15.7.8.1.  Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

15.7.8.1.1.  Drug discovery

15.7.8.1.2.  Drug manufacturing and commercial production

15.7.8.1.3.  Documentation of compliance with FDA regulatory requirements

15.7.8.1.4.  Pre-formulation

15.7.8.1.5.  Providing late-stage clinical trial materials

15.7.8.1.6.  Providing formal stability, scale-up, registration batches

15.7.8.1.7.  API manufacturing

15.7.8.1.8.  Others

15.7.8.2.  Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

15.7.8.2.1.  Autoimmune Diseases

15.7.8.2.2.  Oncology

15.7.8.2.3.  Metabolic Diseases

15.7.8.2.4.  Ophthalmology

15.7.8.2.5.  Cardiovascular Diseases

15.7.8.2.6.  Infectious Diseases

15.7.8.2.7.  Neurology

15.7.8.2.8.  Respiratory Disorders

15.7.8.2.9.  Others

15.7.8.3.  Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

15.7.8.3.1.  Solid

15.7.8.3.1.1. Tablets and Capsules

15.7.8.3.1.2. Compressed tablets

15.7.8.3.1.3. Micro and mini tablets

15.7.8.3.1.4. Aqueous film coated tablets

15.7.8.3.1.5. Others

15.7.8.3.2.  Liquid

15.7.8.3.2.1. Oral Solutions

15.7.8.3.2.2. Topical Solutions

15.7.8.3.3.  Semi-solid

15.7.8.3.3.1. Creams

15.7.8.3.3.2. Gels

15.7.8.3.3.3. Ointments

15.7.8.3.3.4. Others

15.7.8.4.  Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

15.7.8.4.1.  Preclinical

15.7.8.4.2.  Phase 1

15.7.8.4.3.  Phase 2

15.7.8.4.4.  Phase 3

15.7.8.4.5.  Phase 4

15.7.8.4.6.  Commercial

15.7.8.5.  Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

15.7.8.5.1.  Commercial Production

15.7.8.5.1.1. Small scale

15.7.8.5.1.2. Large Scale

15.7.8.5.2.  Clinical Production

15.7.8.5.3.  Aseptic Filling

15.7.8.5.4.  Others

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Service

15.8.3. By Therapeutic Area

15.8.4. By Form

15.8.5. By Clinical Phase

15.8.6. By Process

16. Middle East and Africa Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

16.1. Overview

16.1.1. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

16.2. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.2.1. Drug discovery

16.2.2. Drug manufacturing and commercial production

16.2.3. Documentation of compliance with FDA regulatory requirements

16.2.4. Pre-formulation

16.2.5. Providing late-stage clinical trial materials

16.2.6. Providing formal stability, scale-up, registration batches

16.2.7. API manufacturing

16.2.8. Others

16.3. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.3.1. Autoimmune Diseases

16.3.2. Oncology

16.3.3. Metabolic Diseases

16.3.4. Ophthalmology

16.3.5. Cardiovascular Diseases

16.3.6. Infectious Diseases

16.3.7. Neurology

16.3.8. Respiratory Disorders

16.3.9. Others

16.4. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.4.1. Solid

16.4.1.1.  Tablets and Capsules

16.4.1.2.  Compressed tablets

16.4.1.3.  Micro and mini tablets

16.4.1.4.  Aqueous film coated tablets

16.4.1.5.  Others

16.4.2. Liquid

16.4.2.1.  Oral Solutions

16.4.2.2.  Topical Solutions

16.4.3. Semi-solid

16.4.3.1.  Creams

16.4.3.2.  Gels

16.4.3.3.  Ointments

16.4.3.4.  Others

16.5. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.5.1. Preclinical

16.5.2. Phase 1

16.5.3. Phase 2

16.5.4. Phase 3

16.5.5. Phase 4

16.5.6. Commercial

16.6. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.6.1. Commercial Production

16.6.1.1.  Small scale

16.6.1.2.  Large Scale

16.6.2. Clinical Production

16.6.3. Aseptic Filling

16.6.4. Others

16.7. Middle East and Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.1.1.1.  Drug discovery

16.7.1.1.2.  Drug manufacturing and commercial production

16.7.1.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.1.1.4.  Pre-formulation

16.7.1.1.5.  Providing late-stage clinical trial materials

16.7.1.1.6.  Providing formal stability, scale-up, registration batches

16.7.1.1.7.  API manufacturing

16.7.1.1.8.  Others

16.7.1.2.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.1.2.1.  Autoimmune Diseases

16.7.1.2.2.  Oncology

16.7.1.2.3.  Metabolic Diseases

16.7.1.2.4.  Ophthalmology

16.7.1.2.5.  Cardiovascular Diseases

16.7.1.2.6.  Infectious Diseases

16.7.1.2.7.  Neurology

16.7.1.2.8.  Respiratory Disorders

16.7.1.2.9.  Others

16.7.1.3.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.1.3.1.  Solid

16.7.1.3.1.1. Tablets and Capsules

16.7.1.3.1.2. Compressed tablets

16.7.1.3.1.3. Micro and mini tablets

16.7.1.3.1.4. Aqueous film coated tablets

16.7.1.3.1.5. Others

16.7.1.3.2.  Liquid

16.7.1.3.2.1. Oral Solutions

16.7.1.3.2.2. Topical Solutions

16.7.1.3.3.  Semi-solid

16.7.1.3.3.1. Creams

16.7.1.3.3.2. Gels

16.7.1.3.3.3. Ointments

16.7.1.3.3.4. Others

16.7.1.4.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.1.4.1.  Preclinical

16.7.1.4.2.  Phase 1

16.7.1.4.3.  Phase 2

16.7.1.4.4.  Phase 3

16.7.1.4.5.  Phase 4

16.7.1.4.6.  Commercial

16.7.1.5.  Saudi Arabia Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.1.5.1.  Commercial Production

16.7.1.5.1.1. Small scale

16.7.1.5.1.2. Large Scale

16.7.1.5.2.  Clinical Production

16.7.1.5.3.  Aseptic Filling

16.7.1.5.4.  Others

16.7.2. UAE

16.7.2.1.  UAE Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.2.1.1.  Drug discovery

16.7.2.1.2.  Drug manufacturing and commercial production

16.7.2.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.2.1.4.  Pre-formulation

16.7.2.1.5.  Providing late-stage clinical trial materials

16.7.2.1.6.  Providing formal stability, scale-up, registration batches

16.7.2.1.7.  API manufacturing

16.7.2.1.8.  Others

16.7.2.2.  UAE Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.2.2.1.  Autoimmune Diseases

16.7.2.2.2.  Oncology

16.7.2.2.3.  Metabolic Diseases

16.7.2.2.4.  Ophthalmology

16.7.2.2.5.  Cardiovascular Diseases

16.7.2.2.6.  Infectious Diseases

16.7.2.2.7.  Neurology

16.7.2.2.8.  Respiratory Disorders

16.7.2.2.9.  Others

16.7.2.3.  UAE Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.2.3.1.  Solid

16.7.2.3.1.1. Tablets and Capsules

16.7.2.3.1.2. Compressed tablets

16.7.2.3.1.3. Micro and mini tablets

16.7.2.3.1.4. Aqueous film coated tablets

16.7.2.3.1.5. Others

16.7.2.3.2.  Liquid

16.7.2.3.2.1. Oral Solutions

16.7.2.3.2.2. Topical Solutions

16.7.2.3.3.  Semi-solid

16.7.2.3.3.1. Creams

16.7.2.3.3.2. Gels

16.7.2.3.3.3. Ointments

16.7.2.3.3.4. Others

16.7.2.4.  UAE Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.2.4.1.  Preclinical

16.7.2.4.2.  Phase 1

16.7.2.4.3.  Phase 2

16.7.2.4.4.  Phase 3

16.7.2.4.5.  Phase 4

16.7.2.4.6.  Commercial

16.7.2.5.  UAE Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.2.5.1.  Commercial Production

16.7.2.5.1.1. Small scale

16.7.2.5.1.2. Large Scale

16.7.2.5.2.  Clinical Production

16.7.2.5.3.  Aseptic Filling

16.7.2.5.4.  Others

16.7.3. Egypt

16.7.3.1.  Egypt Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.3.1.1.  Drug discovery

16.7.3.1.2.  Drug manufacturing and commercial production

16.7.3.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.3.1.4.  Pre-formulation

16.7.3.1.5.  Providing late-stage clinical trial materials

16.7.3.1.6.  Providing formal stability, scale-up, registration batches

16.7.3.1.7.  API manufacturing

16.7.3.1.8.  Others

16.7.3.2.  Egypt Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.3.2.1.  Autoimmune Diseases

16.7.3.2.2.  Oncology

16.7.3.2.3.  Metabolic Diseases

16.7.3.2.4.  Ophthalmology

16.7.3.2.5.  Cardiovascular Diseases

16.7.3.2.6.  Infectious Diseases

16.7.3.2.7.  Neurology

16.7.3.2.8.  Respiratory Disorders

16.7.3.2.9.  Others

16.7.3.3.  Egypt Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.3.3.1.  Solid

16.7.3.3.1.1. Tablets and Capsules

16.7.3.3.1.2. Compressed tablets

16.7.3.3.1.3. Micro and mini tablets

16.7.3.3.1.4. Aqueous film coated tablets

16.7.3.3.1.5. Others

16.7.3.3.2.  Liquid

16.7.3.3.2.1. Oral Solutions

16.7.3.3.2.2. Topical Solutions

16.7.3.3.3.  Semi-solid

16.7.3.3.3.1. Creams

16.7.3.3.3.2. Gels

16.7.3.3.3.3. Ointments

16.7.3.3.3.4. Others

16.7.3.4.  Egypt Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.3.4.1.  Preclinical

16.7.3.4.2.  Phase 1

16.7.3.4.3.  Phase 2

16.7.3.4.4.  Phase 3

16.7.3.4.5.  Phase 4

16.7.3.4.6.  Commercial

16.7.3.5.  Egypt Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.3.5.1.  Commercial Production

16.7.3.5.1.1. Small scale

16.7.3.5.1.2. Large Scale

16.7.3.5.2.  Clinical Production

16.7.3.5.3.  Aseptic Filling

16.7.3.5.4.  Others

16.7.4. Kuwait

16.7.4.1.  Kuwait Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.4.1.1.  Drug discovery

16.7.4.1.2.  Drug manufacturing and commercial production

16.7.4.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.4.1.4.  Pre-formulation

16.7.4.1.5.  Providing late-stage clinical trial materials

16.7.4.1.6.  Providing formal stability, scale-up, registration batches

16.7.4.1.7.  API manufacturing

16.7.4.1.8.  Others

16.7.4.2.  Kuwait Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.4.2.1.  Autoimmune Diseases

16.7.4.2.2.  Oncology

16.7.4.2.3.  Metabolic Diseases

16.7.4.2.4.  Ophthalmology

16.7.4.2.5.  Cardiovascular Diseases

16.7.4.2.6.  Infectious Diseases

16.7.4.2.7.  Neurology

16.7.4.2.8.  Respiratory Disorders

16.7.4.2.9.  Others

16.7.4.3.  Kuwait Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.4.3.1.  Solid

16.7.4.3.1.1. Tablets and Capsules

16.7.4.3.1.2. Compressed tablets

16.7.4.3.1.3. Micro and mini tablets

16.7.4.3.1.4. Aqueous film coated tablets

16.7.4.3.1.5. Others

16.7.4.3.2.  Liquid

16.7.4.3.2.1. Oral Solutions

16.7.4.3.2.2. Topical Solutions

16.7.4.3.3.  Semi-solid

16.7.4.3.3.1. Creams

16.7.4.3.3.2. Gels

16.7.4.3.3.3. Ointments

16.7.4.3.3.4. Others

16.7.4.4.  Kuwait Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.4.4.1.  Preclinical

16.7.4.4.2.  Phase 1

16.7.4.4.3.  Phase 2

16.7.4.4.4.  Phase 3

16.7.4.4.5.  Phase 4

16.7.4.4.6.  Commercial

16.7.4.5.  Kuwait Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.4.5.1.  Commercial Production

16.7.4.5.1.1. Small scale

16.7.4.5.1.2. Large Scale

16.7.4.5.2.  Clinical Production

16.7.4.5.3.  Aseptic Filling

16.7.4.5.4.  Others

16.7.5. South Africa

16.7.5.1.  South Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.5.1.1.  Drug discovery

16.7.5.1.2.  Drug manufacturing and commercial production

16.7.5.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.5.1.4.  Pre-formulation

16.7.5.1.5.  Providing late-stage clinical trial materials

16.7.5.1.6.  Providing formal stability, scale-up, registration batches

16.7.5.1.7.  API manufacturing

16.7.5.1.8.  Others

16.7.5.2.  South Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.5.2.1.  Autoimmune Diseases

16.7.5.2.2.  Oncology

16.7.5.2.3.  Metabolic Diseases

16.7.5.2.4.  Ophthalmology

16.7.5.2.5.  Cardiovascular Diseases

16.7.5.2.6.  Infectious Diseases

16.7.5.2.7.  Neurology

16.7.5.2.8.  Respiratory Disorders

16.7.5.2.9.  Others

16.7.5.3.  South Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.5.3.1.  Solid

16.7.5.3.1.1. Tablets and Capsules

16.7.5.3.1.2. Compressed tablets

16.7.5.3.1.3. Micro and mini tablets

16.7.5.3.1.4. Aqueous film coated tablets

16.7.5.3.1.5. Others

16.7.5.3.2.  Liquid

16.7.5.3.2.1. Oral Solutions

16.7.5.3.2.2. Topical Solutions

16.7.5.3.3.  Semi-solid

16.7.5.3.3.1. Creams

16.7.5.3.3.2. Gels

16.7.5.3.3.3. Ointments

16.7.5.3.3.4. Others

16.7.5.4.  South Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.5.4.1.  Preclinical

16.7.5.4.2.  Phase 1

16.7.5.4.3.  Phase 2

16.7.5.4.4.  Phase 3

16.7.5.4.5.  Phase 4

16.7.5.4.6.  Commercial

16.7.5.5.  South Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.5.5.1.  Commercial Production

16.7.5.5.1.1. Small scale

16.7.5.5.1.2. Large Scale

16.7.5.5.2.  Clinical Production

16.7.5.5.3.  Aseptic Filling

16.7.5.5.4.  Others

16.7.6. Rest of Middle East & Africa

16.7.6.1.  Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

16.7.6.1.1.  Drug discovery

16.7.6.1.2.  Drug manufacturing and commercial production

16.7.6.1.3.  Documentation of compliance with FDA regulatory requirements

16.7.6.1.4.  Pre-formulation

16.7.6.1.5.  Providing late-stage clinical trial materials

16.7.6.1.6.  Providing formal stability, scale-up, registration batches

16.7.6.1.7.  API manufacturing

16.7.6.1.8.  Others

16.7.6.2.  Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

16.7.6.2.1.  Autoimmune Diseases

16.7.6.2.2.  Oncology

16.7.6.2.3.  Metabolic Diseases

16.7.6.2.4.  Ophthalmology

16.7.6.2.5.  Cardiovascular Diseases

16.7.6.2.6.  Infectious Diseases

16.7.6.2.7.  Neurology

16.7.6.2.8.  Respiratory Disorders

16.7.6.2.9.  Others

16.7.6.3.  Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

16.7.6.3.1.  Solid

16.7.6.3.1.1. Tablets and Capsules

16.7.6.3.1.2. Compressed tablets

16.7.6.3.1.3. Micro and mini tablets

16.7.6.3.1.4. Aqueous film coated tablets

16.7.6.3.1.5. Others

16.7.6.3.2.  Liquid

16.7.6.3.2.1. Oral Solutions

16.7.6.3.2.2. Topical Solutions

16.7.6.3.3.  Semi-solid

16.7.6.3.3.1. Creams

16.7.6.3.3.2. Gels

16.7.6.3.3.3. Ointments

16.7.6.3.3.4. Others

16.7.6.4.  Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

16.7.6.4.1.  Preclinical

16.7.6.4.2.  Phase 1

16.7.6.4.3.  Phase 2

16.7.6.4.4.  Phase 3

16.7.6.4.5.  Phase 4

16.7.6.4.6.  Commercial

16.7.6.5.  Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

16.7.6.5.1.  Commercial Production

16.7.6.5.1.1. Small scale

16.7.6.5.1.2. Large Scale

16.7.6.5.2.  Clinical Production

16.7.6.5.3.  Aseptic Filling

16.7.6.5.4.  Others

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Service

16.8.3. By Therapeutic Area

16.8.4. By Form

16.8.5. By Clinical Phase

16.8.6. By Process

17. Latin America Pharmaceutical Contract Manufacturing Market Analysis and Forecasts, 2023 – 2031

17.1. Overview

17.1.1. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn)

17.2. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

17.2.1. Drug discovery

17.2.2. Drug manufacturing and commercial production

17.2.3. Documentation of compliance with FDA regulatory requirements

17.2.4. Pre-formulation

17.2.5. Providing late-stage clinical trial materials

17.2.6. Providing formal stability, scale-up, registration batches

17.2.7. API manufacturing

17.2.8. Others

17.3. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

17.3.1. Autoimmune Diseases

17.3.2. Oncology

17.3.3. Metabolic Diseases

17.3.4. Ophthalmology

17.3.5. Cardiovascular Diseases

17.3.6. Infectious Diseases

17.3.7. Neurology

17.3.8. Respiratory Disorders

17.3.9. Others

17.4. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

17.4.1. Solid

17.4.1.1.  Tablets and Capsules

17.4.1.2.  Compressed tablets

17.4.1.3.  Micro and mini tablets

17.4.1.4.  Aqueous film coated tablets

17.4.1.5.  Others

17.4.2. Liquid

17.4.2.1.  Oral Solutions

17.4.2.2.  Topical Solutions

17.4.3. Semi-solid

17.4.3.1.  Creams

17.4.3.2.  Gels

17.4.3.3.  Ointments

17.4.3.4.  Others

17.5. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

17.5.1. Preclinical

17.5.2. Phase 1

17.5.3. Phase 2

17.5.4. Phase 3

17.5.5. Phase 4

17.5.6. Commercial

17.6. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

17.6.1. Commercial Production

17.6.1.1.  Small scale

17.6.1.2.  Large Scale

17.6.2. Clinical Production

17.6.3. Aseptic Filling

17.6.4. Others

17.7. Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1.  Brazil Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

17.7.1.1.1.  Drug discovery

17.7.1.1.2.  Drug manufacturing and commercial production

17.7.1.1.3.  Documentation of compliance with FDA regulatory requirements

17.7.1.1.4.  Pre-formulation

17.7.1.1.5.  Providing late-stage clinical trial materials

17.7.1.1.6.  Providing formal stability, scale-up, registration batches

17.7.1.1.7.  API manufacturing

17.7.1.1.8.  Others

17.7.1.2.  Brazil Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

17.7.1.2.1.  Autoimmune Diseases

17.7.1.2.2.  Oncology

17.7.1.2.3.  Metabolic Diseases

17.7.1.2.4.  Ophthalmology

17.7.1.2.5.  Cardiovascular Diseases

17.7.1.2.6.  Infectious Diseases

17.7.1.2.7.  Neurology

17.7.1.2.8.  Respiratory Disorders

17.7.1.2.9.  Others

17.7.1.3.  Brazil Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

17.7.1.3.1.  Solid

17.7.1.3.1.1. Tablets and Capsules

17.7.1.3.1.2. Compressed tablets

17.7.1.3.1.3. Micro and mini tablets

17.7.1.3.1.4. Aqueous film coated tablets

17.7.1.3.1.5. Others

17.7.1.3.2.  Liquid

17.7.1.3.2.1. Oral Solutions

17.7.1.3.2.2. Topical Solutions

17.7.1.3.3.  Semi-solid

17.7.1.3.3.1. Creams

17.7.1.3.3.2. Gels

17.7.1.3.3.3. Ointments

17.7.1.3.3.4. Others

17.7.1.4.  Brazil Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

17.7.1.4.1.  Preclinical

17.7.1.4.2.  Phase 1

17.7.1.4.3.  Phase 2

17.7.1.4.4.  Phase 3

17.7.1.4.5.  Phase 4

17.7.1.4.6.  Commercial

17.7.1.5.  Brazil Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

17.7.1.5.1.  Commercial Production

17.7.1.5.1.1. Small scale

17.7.1.5.1.2. Large Scale

17.7.1.5.2.  Clinical Production

17.7.1.5.3.  Aseptic Filling

17.7.1.5.4.  Others

17.7.2. Argentina

17.7.2.1.  Argentina Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

17.7.2.1.1.  Drug discovery

17.7.2.1.2.  Drug manufacturing and commercial production

17.7.2.1.3.  Documentation of compliance with FDA regulatory requirements

17.7.2.1.4.  Pre-formulation

17.7.2.1.5.  Providing late-stage clinical trial materials

17.7.2.1.6.  Providing formal stability, scale-up, registration batches

17.7.2.1.7.  API manufacturing

17.7.2.1.8.  Others

17.7.2.2.  Argentina Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

17.7.2.2.1.  Autoimmune Diseases

17.7.2.2.2.  Oncology

17.7.2.2.3.  Metabolic Diseases

17.7.2.2.4.  Ophthalmology

17.7.2.2.5.  Cardiovascular Diseases

17.7.2.2.6.  Infectious Diseases

17.7.2.2.7.  Neurology

17.7.2.2.8.  Respiratory Disorders

17.7.2.2.9.  Others

17.7.2.3.  Argentina Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

17.7.2.3.1.  Solid

17.7.2.3.1.1. Tablets and Capsules

17.7.2.3.1.2. Compressed tablets

17.7.2.3.1.3. Micro and mini tablets

17.7.2.3.1.4. Aqueous film coated tablets

17.7.2.3.1.5. Others

17.7.2.3.2.  Liquid

17.7.2.3.2.1. Oral Solutions

17.7.2.3.2.2. Topical Solutions

17.7.2.3.3.  Semi-solid

17.7.2.3.3.1. Creams

17.7.2.3.3.2. Gels

17.7.2.3.3.3. Ointments

17.7.2.3.3.4. Others

17.7.2.4.  Argentina Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

17.7.2.4.1.  Preclinical

17.7.2.4.2.  Phase 1

17.7.2.4.3.  Phase 2

17.7.2.4.4.  Phase 3

17.7.2.4.5.  Phase 4

17.7.2.4.6.  Commercial

17.7.2.5.  Argentina Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

17.7.2.5.1.  Commercial Production

17.7.2.5.1.1. Small scale

17.7.2.5.1.2. Large Scale

17.7.2.5.2.  Clinical Production

17.7.2.5.3.  Aseptic Filling

17.7.2.5.4.  Others

17.7.3. Rest of Latin America

17.7.3.1.  Rest of Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Service

17.7.3.1.1.  Drug discovery

17.7.3.1.2.  Drug manufacturing and commercial production

17.7.3.1.3.  Documentation of compliance with FDA regulatory requirements

17.7.3.1.4.  Pre-formulation

17.7.3.1.5.  Providing late-stage clinical trial materials

17.7.3.1.6.  Providing formal stability, scale-up, registration batches

17.7.3.1.7.  API manufacturing

17.7.3.1.8.  Others

17.7.3.2.  Rest of Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area

17.7.3.2.1.  Autoimmune Diseases

17.7.3.2.2.  Oncology

17.7.3.2.3.  Metabolic Diseases

17.7.3.2.4.  Ophthalmology

17.7.3.2.5.  Cardiovascular Diseases

17.7.3.2.6.  Infectious Diseases

17.7.3.2.7.  Neurology

17.7.3.2.8.  Respiratory Disorders

17.7.3.2.9.  Others

17.7.3.3.  Rest of Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Form

17.7.3.3.1.  Solid

17.7.3.3.1.1. Tablets and Capsules

17.7.3.3.1.2. Compressed tablets

17.7.3.3.1.3. Micro and mini tablets

17.7.3.3.1.4. Aqueous film coated tablets

17.7.3.3.1.5. Others

17.7.3.3.2.  Liquid

17.7.3.3.2.1. Oral Solutions

17.7.3.3.2.2. Topical Solutions

17.7.3.3.3.  Semi-solid

17.7.3.3.3.1. Creams

17.7.3.3.3.2. Gels

17.7.3.3.3.3. Ointments

17.7.3.3.3.4. Others

17.7.3.4.  Rest of Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Clinical Phase

17.7.3.4.1.  Preclinical

17.7.3.4.2.  Phase 1

17.7.3.4.3.  Phase 2

17.7.3.4.4.  Phase 3

17.7.3.4.5.  Phase 4

17.7.3.4.6.  Commercial

17.7.3.5.  Rest of Latin America Pharmaceutical Contract Manufacturing Market Revenue (US$ Mn) and Forecasts, By Process

17.7.3.5.1.  Commercial Production

17.7.3.5.1.1. Small scale

17.7.3.5.1.2. Large Scale

17.7.3.5.2.  Clinical Production

17.7.3.5.3.  Aseptic Filling

17.7.3.5.4.  Others

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Service

17.8.3. By Therapeutic Area

17.8.4. By Form

17.8.5. By Clinical Phase

17.8.6. By Process

18. Competitive Benchmarking

18.1. Market Share Analysis, 2022

18.2. Global Presence and Growth Strategies

18.2.1. Mergers and Acquisitions

18.2.2. Product Launches

18.2.3. Investments Trends

18.2.4. R&D Initiatives

19. Player Profiles

19.1. AbbVie Inc.

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. Akums Drugs and Pharmaceuticals Ltd.

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. Avara Pharmaceutical Services, Inc

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. Cambrex Corporation

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. Cirondrugs

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. Curia Global, Inc.

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. Datex Corporation.

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8. Jubilant Pharmova Limited

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. Labcorp Drug Development 

19.9.1. Company Details

19.9.2. Company Overview

19.9.3. Product Offerings

19.9.4. Key Developments

19.9.5. Financial Analysis

19.9.6. SWOT Analysis

19.9.7. Business Strategies

19.10. Piramal Pharma Solutions

19.10.1. Company Details

19.10.2. Company Overview

19.10.3. Product Offerings

19.10.4. Key Developments

19.10.5. Financial Analysis

19.10.6. SWOT Analysis

19.10.7. Business Strategies

19.11. Recipharm AB

19.11.1. Company Details

19.11.2. Company Overview

19.11.3. Product Offerings

19.11.4. Key Developments

19.11.5. Financial Analysis

19.11.6. SWOT Analysis

19.11.7. Business Strategies

19.12. Samsung Biologics

19.12.1. Company Details

19.12.2. Company Overview

19.12.3. Product Offerings

19.12.4. Key Developments

19.12.5. Financial Analysis

19.12.6. SWOT Analysis

19.12.7. Business Strategies

19.13. Sovereign Pharmaceuticals.

19.13.1. Company Details

19.13.2. Company Overview

19.13.3. Product Offerings

19.13.4. Key Developments

19.13.5. Financial Analysis

19.13.6. SWOT Analysis

19.13.7. Business Strategies

19.14. Thermo Fisher Scientific Inc

19.14.1. Company Details

19.14.2. Company Overview

19.14.3. Product Offerings

19.14.4. Key Developments

19.14.5. Financial Analysis

19.14.6. SWOT Analysis

19.14.7. Business Strategies

19.15. WuXiAppTec

19.15.1. Company Details

19.15.2. Company Overview

19.15.3. Product Offerings

19.15.4. Key Developments

19.15.5. Financial Analysis

19.15.6. SWOT Analysis

19.15.7. Business Strategies

19.16. Other market participants

20. Key Findings

 

**Exclusive for Multi-User and Enterprise User.

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com